rfhg_207977.1

Basic information about the TSS

---

TSS ID: rfhg_207977.1 Species: human Chr: chr19		Start: 12722367 End: 12722424 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000356861.9:12 GeneID: 30000 HGNC/MGI_ID: HGNC:19998 UniProt_ID: A0A024R7F7 Nearer transcript ids and distances: ENST00000586775.5:80 ENST00000585886.5:-101 BC018314:-101 BC072420:103 NM_001382242.1:108 NM_013433.5:108 NR_167974.1:108 NR_167979.1:108 ENST00000587654.5:-113 ENST00000589956.5:-116 AF019039:-131 LF373376:133 MA608953:133 NM_001136196.2:-136 NM_001382239.1:-136 NM_001382243.1:-136 NR_167978.1:-136 AK299485:-136 LF208193:-137 MA443770:-137 ENST00000592287.5:-148 BC063679:222 LF373377:229 MA608954:229 LF373378:356 MA608955:356 view more...

Gene_name: transportin 2 Gene_symbol: TNPO2 Gene_synonyms: FLJ12155 IPO3 KPNB2B TRN2 Gene_source: HGNC:19998

TATA-Box annotation

---

Distance to TSS:	-136
Nearest PromoterID:	NM_013433
Entrez ID:	30000
Nearest Unigene:	Hs.416049
Nearest Refseq:	NM_013433
Nearest Ensembl:	ENSG00000105576
Gene Name:	transportin 2
Gene Alias:	IPO3|KPNB2B|TRN2
Gene Type:	protein-coding
CpG%:	0.245614
GC%:	0.913793
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TNPO2 p2@TNPO2 p3@TNPO2 p4@TNPO2 p5@TNPO2 p6@TNPO2 p7@TNPO2 p8@TNPO2 p9@TNPO2
Sample		p1@TNPO2	p2@TNPO2	p3@TNPO2	p4@TNPO2	p5@TNPO2	p6@TNPO2	p7@TNPO2	p8@TNPO2	p9@TNPO2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	75.00	30.39	4.68	30.97	0.00	0.19	2.34	0.39	6.04
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	78.09	36.82	3.44	27.92	1.01	0.61	3.44	0.00	4.65
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	84.88	38.97	5.02	31.83	0.19	0.39	1.74	0.00	6.94
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	89.40	42.83	4.37	38.26	0.21	0.21	3.12	0.00	7.48
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	87.29	36.44	4.05	36.67	0.00	0.00	2.92	0.00	7.65
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	101.56	39.73	2.91	33.92	0.19	0.19	2.13	0.00	7.17
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	119.18	48.37	4.14	35.95	0.00	0.44	4.36	0.00	13.07
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	108.27	38.03	2.42	31.00	0.00	0.00	4.36	0.00	6.54
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	102.80	41.03	3.21	40.39	0.43	0.00	2.78	0.21	10.26
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	96.22	93.90	6.38	78.25	0.00	0.58	2.32	0.00	17.39
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	102.27	87.72	7.28	76.00	0.81	0.00	4.04	0.81	23.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	110.99	89.04	8.13	72.77	0.41	0.41	2.85	0.00	25.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	18.86	9.67	9.03	6.29	0.81	0.48	0.16	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.04	5.11	6.16	4.96	0.30	0.90	0.45	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.81	7.25	7.25	5.05	0.00	0.88	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.83	7.54	10.56	5.28	0.25	0.50	0.50	0.25	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.10	6.99	7.86	5.24	0.22	1.09	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.50	6.33	8.44	2.11	0.00	0.84	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.99	7.46	5.86	4.27	0.53	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.28	7.07	6.62	5.27	0.15	1.05	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.17	9.49	8.82	4.01	0.53	0.40	0.27	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.43	6.56	7.42	4.32	0.69	0.52	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	14.09	5.17	6.72	5.95	0.52	0.26	0.78	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.41	5.58	7.28	5.82	0.00	0.49	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.19	12.90	5.42	8.77	0.52	0.26	0.26	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.13	7.91	5.70	3.48	0.95	0.63	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.93	8.79	9.89	3.30	0.00	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.15	6.60	9.67	9.90	0.47	0.71	0.47	0.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.34	3.72	7.27	7.27	0.32	0.81	0.81	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.05	7.78	6.88	6.15	0.54	1.09	0.72	0.18	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.51	7.54	5.44	5.44	0.00	0.84	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.36	6.25	5.86	5.67	0.20	0.39	0.98	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.82	8.44	5.91	5.06	0.00	0.00	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.17	8.41	6.10	5.44	0.16	0.16	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.23	5.42	5.80	8.41	0.19	0.19	0.37	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.81	5.75	6.52	5.37	0.00	0.19	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.34	7.15	5.72	6.13	0.00	0.00	0.20	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.66	9.07	4.03	4.63	0.20	0.40	0.20	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.02	4.86	4.32	7.02	0.54	0.54	0.00	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.72	6.48	4.56	5.52	0.24	0.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.06	5.18	4.94	7.06	0.24	0.24	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.91	5.86	4.39	5.27	0.15	0.00	0.59	0.00	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.65	7.80	2.74	7.38	0.00	0.21	0.42	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.24	6.12	5.77	7.69	0.00	0.00	0.35	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.43	6.42	4.62	7.03	0.00	0.00	0.20	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.44	6.98	5.12	4.19	0.23	0.23	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	5.76	8.16	3.84	4.56	0.00	0.00	0.48	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	4.47	6.26	3.87	4.77	0.00	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	4.07	6.94	4.79	5.51	0.00	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.87	6.87	3.24	5.46	0.20	0.40	0.00	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	5.53	8.61	4.92	8.61	0.00	0.20	0.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.34	14.45	3.56	8.89	0.44	0.00	0.44	0.00	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	3092.27	0.00	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.16	9.94	4.61	13.84	0.00	0.00	0.71	0.00	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.27	11.60	8.62	12.26	0.33	0.33	0.66	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	62.08	0.84	2.52	0.00	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.10	22.50	6.43	4.59	0.46	0.46	0.46	0.00	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.43	18.47	6.16	19.12	0.00	0.32	0.65	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	16.06	5.14	15.09	0.00	0.00	0.00	0.00	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.66	38.66	5.03	6.92	0.00	0.31	0.94	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	16.22	9.87	22.56	0.71	1.41	0.71	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	11.22	7.85	17.38	0.00	0.00	0.56	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	59.71	4.78	4.78	0.00	0.00	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.46	22.76	3.40	11.21	0.00	0.68	1.02	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.80	15.60	7.15	19.17	0.65	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.45	9.58	6.39	11.36	0.71	1.06	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	3523.74	0.00	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	1216.21	0.00	15.79	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.21	4.39	5.36	13.16	0.00	0.00	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.41	4.46	3.97	12.40	0.00	1.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.97	7.51	3.75	7.97	0.94	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.59	14.24	3.97	8.28	1.32	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.19	11.45	3.71	13.61	0.62	2.17	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.31	9.48	6.11	11.31	1.53	0.31	0.00	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	15.84	9.66	10.45	2.38	0.16	0.79	1.58	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	10.59	11.07	6.42	3.85	0.80	1.60	0.64	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	14.89	10.31	9.29	3.31	0.76	2.80	0.64	0.38	0.25
Adipocyte - omental, donor2	11474-119C7	7.47	6.73	9.72	0.75	0.75	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	12.73	9.71	9.04	4.02	1.34	0.33	0.67	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	15.31	8.29	6.38	1.28	0.64	1.91	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.68	1.81	1.81	1.35	0.00	1.35	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.34	7.65	9.91	1.74	0.52	2.78	0.35	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	14.67	10.56	6.26	5.87	0.59	2.15	0.39	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	18.02	4.89	5.15	1.80	0.51	1.03	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	10.87	3.62	3.35	2.23	0.28	1.12	0.84	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	9.99	4.70	4.11	7.05	1.18	1.18	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	20.51	11.34	4.42	9.57	0.80	2.57	0.80	0.97	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	13.23	6.78	6.78	5.81	0.00	1.61	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	4.80	8.00	5.33	1.07	2.67	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	8.90	11.69	5.56	5.56	0.00	0.56	0.56	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	8.32	5.82	5.41	7.07	2.50	2.91	0.42	0.83	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	11.05	4.27	3.27	6.28	0.50	2.51	0.50	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	10.47	7.53	6.22	2.62	0.33	1.96	0.33	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	9.44	6.09	5.18	5.18	1.52	0.61	0.00	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	40.66	3.98	1.99	7.29	0.22	0.66	2.43	0.00	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	38.73	11.12	2.51	8.25	0.36	0.72	1.08	0.00	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	3.59	2.40	2.40	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	17.09	5.04	3.24	5.40	0.36	0.18	0.90	0.00	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	10.04	3.35	6.69	0.00	3.35	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	12.53	7.19	4.73	2.26	0.82	1.44	0.41	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	2.98	3.20	3.20	0.46	1.26	2.06	0.00	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	1.96	3.67	6.37	0.49	2.20	3.43	0.24	1.71	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	9.44	6.29	5.39	3.15	0.45	2.25	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	10.85	7.38	3.91	0.43	0.43	2.17	0.00	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	4.28	0.00	2.14	0.00	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.06	7.77	4.78	1.49	0.90	1.20	0.30	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	6.32	1.26	3.79	0.00	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	10.56	10.56	5.28	1.32	0.00	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.42	4.55	3.57	2.92	0.65	0.65	0.65	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.17	4.37	4.37	2.91	0.97	1.46	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	10.10	8.31	2.38	0.59	1.78	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	5.65	3.39	3.01	0.38	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	8.71	2.90	0.73	1.45	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	7.52	6.27	1.25	2.51	2.51	1.25	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.55	3.79	4.28	0.66	0.33	1.32	0.16	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	1.36	4.09	0.00	0.00	0.00	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.90	6.03	2.87	3.02	0.15	0.90	0.45	0.60	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.11	11.25	7.50	2.68	0.54	1.61	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.69	5.48	4.35	0.38	0.57	1.89	0.38	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.83	8.02	6.68	0.53	0.80	2.14	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	5.85	5.85	0.00	0.98	0.98	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.80	6.14	5.81	1.16	0.83	1.99	0.83	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	6.00	3.60	3.60	0.00	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	10.62	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.09	6.18	5.49	2.23	0.69	1.37	0.51	0.69	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	12.58	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.19	7.28	3.40	2.91	0.49	0.49	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.25	6.07	6.45	1.90	1.52	1.14	0.38	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	8.48	6.06	1.21	0.00	4.85	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	6.27	3.99	2.85	0.57	1.14	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.98	5.34	5.56	1.92	0.64	1.28	0.21	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.32	8.26	7.23	0.77	0.00	1.81	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.85	4.69	5.63	1.41	0.47	2.82	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.65	9.00	2.89	2.25	0.64	1.93	0.64	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	13.56	7.85	4.99	2.14	0.00	0.00	1.43	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	4.68	0.58	2.92	1.75	2.34	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.33	7.23	4.52	3.91	0.00	1.51	0.60	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	8.32	7.13	2.38	0.00	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	4.07	2.03	3.56	2.03	1.53	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.73	5.09	4.33	1.78	0.51	1.53	0.51	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	6.35	6.35	1.27	0.00	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.10	4.75	5.61	0.86	0.00	0.86	0.43	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.95	5.93	5.72	2.96	0.42	1.06	0.42	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.86	8.12	6.38	2.61	0.87	0.87	0.29	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	4.72	1.89	2.83	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.98	5.76	4.07	1.70	0.85	0.68	0.68	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	4.63	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	6.34	6.34	0.00	2.11	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.86	6.65	4.93	2.36	0.64	0.86	0.64	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	8.42	4.21	3.01	0.00	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	6.56	2.92	2.92	2.19	0.00	0.00	0.73	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.05	5.75	8.28	2.07	0.69	0.46	0.46	0.23	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	10.20	12.75	0.00	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.63	7.12	5.59	4.07	0.25	0.51	0.76	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.50	6.81	5.99	2.06	0.83	3.10	0.41	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.34	7.04	7.34	4.59	0.61	1.84	0.61	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.91	8.60	5.26	2.39	0.96	0.00	0.48	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.76	8.43	5.10	3.99	0.67	1.33	0.22	0.89	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	12.21	3.05	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	7.75	4.43	3.88	0.00	1.66	0.55	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.53	7.94	6.62	1.85	1.85	1.32	0.26	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.18	8.36	4.00	3.63	0.36	0.36	0.73	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	40.65	14.74	7.61	6.51	1.47	1.47	1.72	0.25	0.74
Astrocyte - cerebellum, donor2	11580-120F5	31.66	14.89	9.58	6.33	1.88	0.86	1.03	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	16.15	9.44	7.55	3.78	1.47	0.63	0.84	0.84	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	23.36	15.69	9.06	4.88	2.09	1.05	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	31.06	14.72	5.01	5.18	2.43	1.29	0.97	0.16	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	28.19	9.70	6.56	8.35	2.68	0.89	0.75	0.30	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	55.16	5.16	1.61	4.13	0.23	0.57	2.64	0.11	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	61.26	4.89	2.26	4.51	0.13	0.75	2.76	0.13	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.56	5.35	1.59	4.44	0.23	0.34	2.50	0.23	0.23
Basophils, donor1	12241-129G9	2.35	1.57	2.09	1.57	0.00	0.00	0.26	0.00	0.00
Basophils, donor2	12242-129H1	4.33	3.25	6.49	1.80	0.00	0.36	0.36	0.00	0.00
Basophils, donor3	12243-129H2	1.47	3.53	3.82	2.50	0.00	0.29	0.29	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	34.93	3.23	3.88	2.59	0.43	3.02	0.65	0.86	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	27.43	6.40	3.66	5.94	0.46	0.46	0.91	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	27.62	4.39	1.88	7.53	0.00	0.63	3.14	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	23.08	5.82	3.74	3.54	1.04	1.87	2.08	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	17.96	4.15	2.07	1.61	2.30	1.84	1.15	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	20.33	3.60	4.14	2.34	2.70	1.98	0.54	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	32.87	8.55	4.33	6.70	0.10	0.21	2.16	0.00	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	90.60	10.25	1.86	11.18	0.00	0.00	3.26	0.00	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	31.02	2.88	1.28	1.60	0.00	0.00	3.20	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	2.82	2.82	5.64	5.07	0.00	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	1.86	6.12	6.12	1.48	0.19	0.19	0.19	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	3.07	5.93	5.49	5.05	0.44	0.00	1.10	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.23	4.25	2.55	3.40	1.13	2.83	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	7.20	7.20	1.52	4.55	0.38	1.52	0.38	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.26	5.59	1.64	1.97	0.66	2.30	0.00	0.66	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	0.87	6.65	3.47	2.60	0.00	0.43	0.00	0.43	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	0.60	3.02	1.51	2.72	0.00	0.30	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	0.24	4.03	2.61	3.32	0.00	0.71	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.50	4.85	2.85	3.18	0.17	0.33	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.28	4.42	2.21	2.48	0.00	0.28	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.74	3.97	1.49	4.46	0.00	0.00	0.25	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1.37	3.13	2.55	1.57	0.00	0.20	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.36	2.31	1.60	0.53	0.00	0.18	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.44	0.44	1.96	1.96	0.22	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.70	5.62	1.64	3.51	0.00	1.40	0.23	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.11	3.17	1.06	2.64	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	2.22	3.33	8.87	0.00	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.15	4.02	1.93	1.78	0.00	0.74	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.60	3.19	0.60	2.20	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.42	2.08	1.04	3.12	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.23	7.09	3.43	2.75	0.23	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.90	1.81	1.81	1.36	0.00	0.45	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	3.06	0.44	1.75	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.81	3.50	1.88	1.34	0.27	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.05	2.44	1.22	1.57	0.00	0.52	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	2.10	2.52	2.52	0.00	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.37	4.41	2.02	3.86	0.18	0.55	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.70	1.41	2.47	2.82	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	2.19	0.88	3.51	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.35	3.31	1.57	1.74	0.17	0.70	0.35	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	1.49	2.60	1.49	0.00	0.74	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.43	2.16	1.94	1.72	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1.23	5.73	5.32	2.87	0.41	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.93	2.09	1.62	1.85	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.46	4.18	2.32	3.71	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	1.96	1.53	0.44	1.74	0.00	0.00	0.22	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	2.31	2.77	0.46	2.31	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	3.25	1.95	0.22	3.03	0.00	0.65	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	3.43	4.52	0.93	2.80	0.00	0.62	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	1.75	3.67	1.05	2.10	0.00	0.52	0.00	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	3.12	1.78	0.67	4.46	0.00	0.22	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	1.79	5.61	0.26	2.55	0.00	0.00	0.00	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	1.54	3.51	0.66	3.07	0.22	0.44	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.84	3.16	0.00	3.79	0.00	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	18.29	10.16	2.03	8.13	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.14	9.49	3.39	6.10	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	11.39	8.28	2.07	4.14	0.00	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	11.73	6.93	3.73	3.73	0.00	2.67	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	10.19	6.97	2.14	3.75	0.54	2.68	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	7.02	4.91	6.32	0.00	0.70	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8.63	7.06	0.00	3.14	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	9.23	9.23	0.00	3.95	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	13.97	9.04	13.15	5.75	0.00	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	10.16	5.80	18.14	4.35	0.00	0.73	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	10.10	7.07	8.08	5.05	0.00	0.00	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	27.48	18.99	2.02	27.88	0.00	0.81	0.40	0.81	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	17.18	22.37	3.99	25.97	0.00	0.80	0.40	0.00	1.60
CD34+ Progenitors, donor1	11545-120B6	17.07	3.01	10.04	2.01	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	5.62	4.49	13.48	0.00	0.00	0.56	1.69	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	38.70	3.38	1.13	2.63	0.00	0.00	0.75	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	53.67	4.28	1.58	1.58	0.00	0.00	2.48	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	13.93	6.78	17.14	1.43	0.00	1.43	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	7.35	12.25	23.88	3.67	0.00	1.22	0.00	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	7.32	8.23	18.60	4.57	0.30	0.61	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.16	5.10	3.83	2.81	0.26	1.79	0.00	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.28	10.11	5.17	4.49	0.00	0.90	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	12.65	9.20	6.90	3.16	0.57	2.01	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	11.85	9.48	12.33	2.84	0.47	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	21.07	10.53	9.13	3.51	0.00	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	16.48	13.18	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7.80	6.36	6.79	4.19	0.43	0.43	0.00	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	15.93	11.52	12.71	4.24	0.00	0.68	0.85	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.41	12.57	7.90	6.45	0.00	1.13	0.32	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	6.28	8.97	6.72	2.24	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	5.24	5.24	7.34	2.45	0.35	0.35	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	4.40	4.84	6.60	4.40	0.00	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.49	8.01	8.01	5.06	0.00	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.09	17.04	13.09	7.48	0.00	1.45	0.21	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	8.69	16.37	11.69	10.02	0.33	1.34	0.67	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	24.20	7.89	17.68	3.81	0.00	0.82	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	18.76	6.97	19.83	4.82	0.00	2.14	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	12.55	16.14	5.38	3.59	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.91	10.75	9.46	5.56	0.00	2.04	0.93	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	16.68	8.66	8.01	4.55	0.00	1.08	0.22	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	11.98	11.98	11.98	8.62	0.21	1.68	0.00	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6.57	10.11	5.56	3.03	0.51	1.52	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6.93	6.93	7.80	1.30	0.43	1.73	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	13.07	5.23	8.28	2.18	0.00	0.87	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	12.87	8.41	10.39	4.95	0.00	0.99	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	6.46	4.62	2.77	0.00	2.77	0.00	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	15.35	4.19	4.19	0.00	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	15.51	8.86	9.42	1.94	0.28	1.11	0.55	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	18.40	8.10	11.53	1.47	0.25	1.96	0.49	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	4.62	6.16	0.00	0.00	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	12.53	6.80	6.45	3.22	0.72	1.79	0.72	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	6.92	13.85	2.77	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	12.44	6.88	10.48	3.27	0.98	0.65	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	6.38	10.51	18.40	2.63	0.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	12.12	8.08	18.18	3.28	0.25	1.77	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	61.71	12.62	3.67	9.86	0.00	1.38	2.52	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	55.60	11.50	2.16	10.06	0.00	0.24	2.16	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	61.28	16.96	1.92	9.58	0.00	0.55	2.19	0.27	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	75.65	15.31	1.80	14.71	0.30	0.60	3.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	53.28	12.48	5.76	12.96	0.00	0.48	1.44	0.00	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	56.39	14.10	4.09	16.60	0.45	0.23	2.27	0.45	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	78.22	12.60	1.52	15.21	0.00	0.87	2.17	0.43	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	82.12	19.48	2.37	16.58	0.26	0.79	2.11	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	75.98	13.37	1.64	11.02	0.47	0.23	2.81	0.00	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	65.81	14.19	2.72	16.30	0.60	0.60	3.02	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	59.84	13.94	2.03	10.46	0.58	1.74	2.61	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	59.41	11.99	1.33	15.19	0.00	0.00	4.00	0.27	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.89	16.63	3.06	13.57	0.88	1.31	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.05	18.67	5.92	16.40	0.00	0.46	1.37	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	27.60	20.14	4.48	20.88	0.00	1.49	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	52.94	15.49	1.08	13.33	0.36	0.72	2.16	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	56.68	15.82	2.59	14.39	0.58	0.58	3.16	0.00	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	51.15	12.73	3.06	14.85	0.24	0.24	1.89	0.24	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	89.05	11.73	2.54	11.73	0.00	0.95	2.85	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	83.96	13.84	3.08	13.84	0.00	0.92	1.85	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	81.75	12.82	2.89	12.18	0.00	0.96	3.85	0.00	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	61.58	13.39	4.21	11.86	0.38	0.38	3.06	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	63.84	10.64	2.76	9.46	0.39	1.58	1.97	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	60.51	21.18	2.27	11.35	0.00	0.00	3.03	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.12	26.50	8.83	16.06	0.00	0.00	0.00	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.28	30.77	7.69	13.99	0.00	1.40	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	26.05	18.03	7.01	25.04	0.00	3.01	1.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	3.66	3.66	20.11	3.66	7.31	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	6.92	3.95	2.96	2.96	0.99	1.48	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	6.63	1.79	3.47	0.63	0.11	0.53	0.32	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	8.67	12.83	8.32	8.32	0.69	2.08	0.69	0.35	1.39
Chondrocyte - de diff, donor2	11338-117F6	7.46	3.91	6.40	3.20	0.71	2.13	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	5.80	6.37	7.74	2.62	0.34	2.62	0.00	0.46	0.11
Chondrocyte - re diff, donor2	11339-117F7	16.11	3.58	6.27	1.79	0.00	2.69	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	5.66	4.85	8.90	2.83	0.00	2.43	0.00	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	25.94	8.15	7.23	2.41	2.07	1.03	0.80	0.23	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	18.60	4.49	4.28	4.49	0.86	0.21	1.28	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	20.18	5.49	5.22	3.36	1.86	0.80	1.42	0.44	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	12.93	16.05	20.72	4.49	9.08	6.51	0.28	2.93	0.92
Corneal Epithelial Cells, donor1	11526-119I5	46.11	6.15	4.83	5.27	0.22	2.20	2.20	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	34.13	14.79	5.69	10.24	0.00	1.14	2.28	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	31.44	8.44	4.35	3.32	1.02	2.05	1.02	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.60	2.31	1.16	0.99	0.00	1.16	1.49	0.66	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.20	2.52	0.63	0.95	0.32	0.95	2.21	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	3.45	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.83	1.19	0.11	1.40	0.43	0.97	0.76	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	12.64	3.76	1.37	1.37	0.34	0.68	2.39	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.67	3.92	3.92	4.57	0.65	0.00	2.61	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	14.52	2.90	3.39	2.42	0.48	0.00	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	11.51	3.17	2.33	2.84	0.50	0.83	0.50	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	2.35	2.93	1.17	0.00	1.76	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	15.27	4.24	2.83	5.66	0.57	0.85	0.85	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	12.19	5.50	8.26	1.57	0.00	1.57	0.79	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	15.13	3.49	5.82	2.04	0.58	1.45	0.87	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	17.18	7.29	2.59	2.12	0.47	0.94	0.00	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	18.58	3.51	1.93	2.45	0.18	0.70	0.53	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.74	3.32	3.10	2.44	0.89	0.66	0.89	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.30	5.78	3.04	4.56	0.30	0.00	0.61	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	17.20	4.23	4.51	1.69	0.56	2.26	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	9.21	5.35	4.16	0.89	0.30	0.30	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	14.06	6.25	4.69	1.56	0.00	1.04	0.52	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	4.54	4.96	7.66	1.70	0.85	2.13	0.14	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	31.61	7.60	4.40	4.40	0.40	1.60	1.20	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	3.67	4.19	1.57	0.00	1.57	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	19.38	5.84	3.23	4.35	0.99	1.24	0.62	0.00	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	8.91	4.78	4.13	3.04	1.09	0.43	0.43	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.82	5.37	2.20	4.52	0.49	0.49	0.85	0.24	0.85
Endothelial Cells - Vein, donor1	11267-116G7	15.93	0.00	4.55	2.28	1.14	0.00	1.14	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	14.67	3.49	1.40	1.40	0.00	2.79	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	13.50	3.45	2.98	3.61	0.31	1.41	0.63	0.00	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	6.60	21.45	0.00	0.00	0.00	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	0.00	10.70	14.27	7.13	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	30.30	3.66	3.66	5.86	0.24	0.73	0.73	0.73	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	24.96	4.16	8.32	4.16	0.00	0.00	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	2.87	12.73	8.21	2.05	0.82	0.82	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.87	2.96	3.39	2.96	0.55	0.77	0.22	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.34	3.25	5.09	2.17	0.65	0.76	0.11	0.00	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	13.95	5.22	3.52	1.58	0.36	0.97	0.49	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	46.40	12.42	11.19	7.10	0.82	3.96	3.14	1.09	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.39	4.01	6.22	1.16	0.42	1.90	0.84	0.84	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.61	10.54	14.23	5.53	0.53	5.53	0.53	1.32	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	10.63	5.65	3.99	1.99	0.33	1.33	0.00	0.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	14.52	4.54	7.26	3.63	1.36	1.36	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	11.37	2.27	0.76	5.31	0.76	1.52	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	11.20	3.94	4.57	3.00	0.95	1.58	0.47	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	13.64	3.94	6.06	4.85	0.91	2.12	0.61	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	13.83	4.57	6.22	1.78	1.65	1.40	0.63	0.76	0.13
Fibroblast - Cardiac, donor6	11460-119B2	19.40	6.06	3.34	3.79	0.30	0.45	1.82	0.15	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.75	9.78	7.77	2.41	0.80	1.47	0.27	0.54	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	6.04	3.45	9.92	0.00	2.16	2.16	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	4.39	0.00	7.32	2.93	0.00	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	53.05	7.61	5.07	7.38	1.61	2.31	0.92	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	6.28	5.60	11.87	1.19	0.85	2.88	0.00	0.68	0.00
Fibroblast - Dermal, donor1	11269-116G9	18.55	1.88	0.94	0.94	0.00	1.17	0.47	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	29.24	1.89	1.89	2.36	0.00	0.00	0.47	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	13.66	1.57	1.69	1.45	0.36	0.73	0.73	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	20.24	4.52	1.47	4.30	0.57	0.90	1.02	0.23	0.45
Fibroblast - Dermal, donor5	11454-119A5	24.77	4.19	1.22	4.19	0.70	0.35	0.87	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	29.07	7.47	1.14	5.20	1.30	0.16	1.30	0.00	0.81
Fibroblast - Gingival, donor1	11237-116D4	20.20	3.33	2.29	2.29	0.21	2.50	0.42	0.21	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	9.96	7.86	7.60	4.45	1.31	4.19	0.52	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	20.29	6.85	1.84	2.90	0.79	1.19	0.40	0.13	0.40
Fibroblast - Gingival, donor3	11394-118C8	9.19	3.87	5.51	2.22	1.45	3.09	0.10	0.77	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	11.43	9.35	6.23	7.27	1.04	4.16	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.34	7.58	6.34	2.47	0.18	3.52	0.18	0.70	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	10.13	13.10	5.14	7.17	1.09	1.56	0.16	0.47	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.01	8.38	3.65	6.36	1.08	2.84	0.14	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.23	6.35	5.65	8.82	1.06	1.06	1.06	0.35	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	9.07	10.09	4.24	5.41	0.88	3.36	0.29	0.44	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.18	8.59	3.95	5.05	1.36	1.50	0.41	0.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.00	10.86	3.62	9.21	0.88	0.99	0.44	0.33	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.02	7.63	8.80	3.67	1.47	3.52	0.00	0.29	0.15
Fibroblast - Lung, donor1	11270-116H1	17.67	4.08	4.08	1.36	1.36	2.72	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	1.49	1.49	2.98	1.49	2.98	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	19.20	5.06	3.17	2.95	0.84	0.84	0.84	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	39.99	4.17	3.33	2.50	0.00	0.83	0.00	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	1.40	0.00	2.80	1.40	1.40	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	13.15	3.92	4.20	1.68	0.56	1.12	0.56	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	31.26	3.65	2.44	7.71	0.41	2.03	1.22	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	43.94	7.99	3.99	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	11.91	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.20	6.21	2.52	2.33	0.58	0.78	0.19	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.11	8.80	2.12	3.79	1.37	1.52	0.61	0.30	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.56	3.67	1.53	3.67	1.22	1.22	0.61	0.31	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.92	4.58	4.20	9.16	0.76	1.91	0.00	1.53	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	6.48	6.21	2.16	1.89	1.35	2.43	0.27	1.08	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	5.91	6.38	4.41	4.87	1.04	3.25	0.23	0.58	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.60	3.65	1.99	1.22	0.55	0.44	0.66	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	27.63	9.14	3.25	7.52	1.42	2.03	0.61	0.20	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.72	4.01	3.34	9.35	0.00	0.67	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.93	3.16	1.19	0.40	0.79	1.58	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.40	19.65	11.31	7.94	0.99	3.77	1.59	0.60	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.39	4.09	3.20	2.84	0.53	1.24	0.18	1.07	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.42	4.93	6.90	5.52	1.18	2.76	0.39	0.59	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	33.70	15.04	8.12	8.72	0.60	3.61	2.11	0.30	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.09	7.56	3.99	5.61	0.43	2.27	0.65	0.54	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.98	15.69	9.36	4.56	0.51	6.58	0.25	0.25	1.27
Fibroblast - skin normal, donor1	11553-120C5	9.35	5.41	6.23	1.97	0.82	2.63	0.66	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	45.11	21.86	8.22	16.24	1.00	4.41	1.80	0.40	1.20
Fibroblast - skin normal, donor2	11561-120D4	12.36	7.74	4.82	4.32	1.21	2.31	0.50	0.70	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.81	26.29	14.81	8.76	2.42	5.74	0.91	0.91	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.60	7.12	4.81	4.31	0.58	2.57	0.25	0.41	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.48	8.21	7.86	2.91	0.34	2.39	0.51	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.69	17.08	9.52	5.25	0.66	4.60	0.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.62	8.31	4.90	4.58	0.53	2.02	0.32	0.43	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	18.55	4.72	3.54	6.41	1.69	2.19	1.35	0.00	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.61	3.45	2.51	0.63	0.78	1.10	0.16	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	177.28	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	12.20	22.66	5.23	0.87	3.49	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.86	5.89	3.81	1.73	0.87	1.56	1.39	1.04	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	28.11	5.47	3.12	6.77	0.52	1.56	2.86	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.85	5.62	4.09	6.39	0.26	1.53	2.04	0.51	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	35.98	16.08	3.83	11.48	0.00	0.00	1.53	0.00	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	35.73	13.40	1.91	15.31	0.00	0.00	3.19	0.00	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	56.77	26.24	0.57	13.98	0.00	0.00	1.43	0.29	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	35.02	21.23	12.68	18.20	4.41	1.10	0.28	0.55	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	22.15	28.31	18.72	18.49	0.68	0.23	1.14	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	41.61	19.61	3.37	18.43	0.79	0.20	0.99	0.00	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	29.87	23.53	9.52	19.56	3.97	1.32	0.00	0.00	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	28.05	30.33	25.11	30.66	2.28	0.00	0.33	0.00	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	73.41	16.36	1.77	19.46	0.44	1.77	4.42	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	42.96	4.38	5.09	6.50	1.98	1.41	1.27	0.14	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	29.68	5.91	6.90	3.57	3.20	1.11	0.99	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	46.74	7.25	3.76	3.49	1.07	0.54	0.54	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	25.03	4.46	4.34	5.70	2.23	0.74	0.87	0.12	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	25.89	6.51	4.43	6.09	1.66	0.42	0.97	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	31.11	9.56	2.24	5.08	0.41	0.20	1.02	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	25.10	7.53	9.58	4.56	2.51	0.46	1.37	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	19.93	5.23	5.73	3.11	2.62	1.37	0.37	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.42	5.90	8.31	3.93	1.75	1.09	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.96	9.16	11.23	5.32	3.55	0.89	1.77	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.32	5.09	7.79	3.97	3.34	0.95	0.64	0.48	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.33	8.27	7.82	3.57	2.01	1.12	0.67	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	23.99	7.26	9.28	4.03	2.22	0.60	1.21	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.07	5.77	6.45	5.26	1.87	1.02	1.02	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	39.28	9.84	7.54	5.94	1.60	1.24	1.33	0.27	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.54	12.80	12.69	3.54	2.29	0.94	1.66	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	41.16	6.83	11.78	3.07	2.05	1.02	1.20	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.35	4.87	9.74	4.98	3.87	0.66	1.22	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.78	7.24	8.57	5.41	1.91	1.50	2.08	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.51	4.29	7.35	5.10	1.43	0.61	1.43	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.28	6.19	8.87	4.13	2.48	1.24	1.44	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	24.21	7.96	13.14	5.07	3.23	0.81	1.15	0.00	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	24.18	7.50	8.17	3.84	2.50	0.67	1.50	0.50	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.37	7.49	14.11	4.19	2.87	1.76	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.69	6.15	11.68	3.57	4.43	1.23	0.74	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	25.61	8.59	8.92	5.02	2.59	0.16	1.62	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	31.11	9.62	13.79	3.21	3.85	1.28	0.64	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.00	6.06	8.62	3.88	4.26	0.47	1.23	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.47	8.38	6.80	3.16	1.42	0.79	0.95	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	23.11	11.25	8.51	2.43	2.74	0.30	1.82	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	24.25	4.70	8.26	3.87	2.09	0.63	1.36	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.61	8.12	11.42	2.85	1.54	1.32	1.10	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.93	11.78	13.47	1.40	2.81	1.40	1.12	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.33	5.56	8.80	2.87	1.76	0.46	1.94	0.28	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.08	6.15	9.09	2.94	1.07	0.80	2.14	0.53	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.99	5.81	5.51	2.60	1.53	0.46	1.53	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.24	4.66	4.40	4.02	1.55	0.65	1.81	0.26	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.43	4.88	13.55	1.63	1.90	1.08	1.36	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.41	8.66	11.06	3.32	2.21	1.66	2.03	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.93	7.46	13.82	2.85	2.85	0.88	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	18.84	9.92	35.70	0.00	0.00	1.98	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.58	8.71	14.11	2.51	1.19	2.24	1.06	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.54	8.47	12.11	2.62	2.02	2.42	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	33.80	17.03	41.68	0.25	2.54	5.85	1.78	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	65.89	6.57	1.79	5.77	1.00	0.40	1.59	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	50.38	4.31	1.08	3.39	2.00	0.31	1.39	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	62.19	4.71	1.84	5.11	0.82	0.61	2.05	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.26	10.33	2.82	9.07	0.63	0.31	0.63	0.00	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	37.01	8.48	1.70	8.19	0.85	0.00	0.57	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	55.34	9.69	1.38	8.76	2.77	0.46	2.31	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	32.17	9.90	2.47	12.37	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	44.48	10.06	1.93	6.96	1.16	1.16	2.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	52.95	17.65	1.60	8.02	0.00	0.00	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	15.65	0.00	12.17	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	25.39	8.79	1.30	5.86	1.30	0.00	1.95	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	26.77	10.30	4.53	4.94	0.82	0.41	3.71	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	16.66	0.00	16.66	0.00	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	26.85	9.79	2.24	6.15	0.84	1.12	0.56	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	24.84	4.90	1.63	7.52	0.65	0.98	0.65	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	6.71	5.03	9.23	2.52	0.00	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.76	6.36	1.59	5.41	1.59	0.32	0.95	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	17.32	9.85	2.38	4.76	0.34	1.02	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	6.26	4.18	4.18	2.09	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.90	4.01	8.02	4.58	0.57	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.10	9.77	3.85	5.03	0.00	0.59	0.30	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	13.55	5.08	5.08	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.85	9.53	2.49	4.56	1.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	19.56	9.21	5.29	7.59	0.46	0.69	0.23	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	10.54	15.81	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	17.30	9.99	3.84	6.15	0.38	1.54	0.77	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	13.36	10.76	4.89	5.22	0.65	0.00	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.70	4.68	3.34	6.02	1.34	0.67	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.41	5.39	5.39	2.31	0.77	0.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.02	21.57	5.48	14.04	1.37	0.34	3.42	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	7.45	4.97	2.48	0.00	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	24.06	9.44	9.91	2.83	1.42	0.00	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.09	6.64	5.43	6.03	1.81	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	6.10	4.58	9.66	1.02	0.51	1.02	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.14	8.38	3.59	5.98	1.99	0.40	0.40	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.79	8.39	2.47	4.93	0.99	0.49	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	8.26	5.90	10.62	0.00	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.09	7.58	6.42	6.42	1.75	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.97	6.58	5.27	2.19	2.19	0.88	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	17.80	4.24	5.93	5.93	1.70	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	12.54	10.15	6.57	0.60	0.00	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.19	5.82	7.76	4.37	0.97	0.00	1.94	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	2.28	4.57	3.42	0.00	0.00	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.82	6.24	4.99	1.66	0.83	3.33	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	1.12	9.00	3.37	0.00	2.25	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.71	3.17	6.34	0.32	0.95	1.27	0.00	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	3.76	4.18	0.00	0.42	0.42	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.68	7.89	1.04	6.03	0.23	0.12	0.93	0.12	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	19.24	6.92	1.35	6.41	0.17	0.17	0.68	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	18.43	3.87	1.82	4.32	0.23	0.23	1.14	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	19.02	7.21	1.20	4.92	0.11	0.33	1.53	0.11	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	16.33	7.52	0.86	5.37	0.64	0.64	1.29	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.04	5.81	0.86	5.60	0.22	0.22	0.86	0.00	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.82	8.22	1.00	4.86	0.50	0.12	1.37	0.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.24	7.55	0.69	7.38	0.17	0.00	0.69	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.49	6.09	0.32	6.73	0.32	0.00	0.64	0.00	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.31	5.04	3.92	2.80	0.00	0.56	1.12	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	29.86	9.52	4.33	8.66	0.87	0.43	1.30	0.00	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	5.29	2.64	0.00	0.00	2.64	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	23.28	4.94	3.88	6.35	0.35	0.35	0.35	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	18.89	7.27	10.17	2.91	2.18	2.18	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.67	2.45	2.10	2.97	0.35	0.70	0.52	0.17	0.35
Hepatocyte, donor1	11523-119I2	0.00	4.84	2.42	4.84	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	3.23	15.08	2.15	6.46	0.00	3.23	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	6.75	3.07	1.84	6.14	0.00	0.61	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	91.38	15.66	11.10	9.79	0.65	0.00	4.57	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	28.14	6.47	4.89	3.67	0.35	1.22	1.05	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.21	3.29	2.74	3.02	0.14	1.51	1.10	0.27	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	200.59	35.02	3.18	38.21	0.00	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	20.03	6.68	6.68	0.00	0.00	6.68	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	297.92	162.50	0.00	27.08	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	157.82	38.76	9.69	37.38	0.00	0.00	5.54	0.00	24.92
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	47.55	10.01	7.51	12.51	0.00	0.00	0.00	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	83.08	0.00	59.34	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	202.47	43.57	0.00	71.76	0.00	2.56	2.56	0.00	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	9.14	4.57	13.71	0.00	0.00	0.00	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	173.80	37.36	6.50	45.48	0.00	4.87	6.50	0.00	12.99
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	143.39	25.01	1.67	30.01	0.00	0.00	3.33	0.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	3.63	7.26	18.15	0.00	3.63	3.63	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	170.73	42.35	1.32	39.70	0.00	0.00	2.65	0.00	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	105.32	32.15	3.33	35.48	0.00	1.11	6.65	0.00	9.98
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	20.95	0.00	47.14	0.00	5.24	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	134.79	27.08	3.15	29.60	0.00	1.26	7.56	0.00	10.71
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	137.65	41.76	6.19	38.67	0.00	0.00	3.09	0.00	13.92
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	43.90	0.00	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	154.40	32.30	4.52	32.95	0.00	1.94	5.81	0.00	10.34
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	185.14	51.52	1.61	56.35	1.61	0.00	3.22	1.61	14.49
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	23.90	0.00	83.64	0.00	11.95	0.00	0.00	23.90
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	175.20	32.60	4.07	48.08	0.81	0.81	11.41	0.00	15.48
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	147.35	44.08	6.72	48.28	0.42	2.10	11.33	0.00	11.33
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	57.49	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	135.82	40.99	3.21	41.79	0.80	1.61	3.21	0.80	20.90
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	78.48	36.93	3.69	41.55	0.00	2.77	3.69	0.92	11.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	15.08	15.08	105.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	87.80	19.83	1.89	19.35	0.00	1.89	3.78	0.00	7.55
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	126.07	44.44	6.35	45.35	0.00	0.91	2.72	0.91	9.98
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	162.17	29.48	29.48	73.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	177.56	46.27	8.61	66.72	1.08	2.15	8.61	1.08	12.91
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	172.78	49.55	6.35	73.69	0.00	1.27	7.62	0.00	17.79
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	16.43	65.72	0.00	0.00	0.00	0.00	49.29
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	160.06	47.83	8.93	60.58	0.64	5.10	4.46	0.00	20.41
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	202.32	72.91	7.29	80.20	0.00	1.82	12.76	0.00	27.34
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00	158.04	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	152.10	69.98	12.14	64.27	0.71	5.00	5.71	0.00	12.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	292.01	99.55	13.27	96.23	0.00	0.00	3.32	0.00	19.91
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	271.03	41.70	20.85	208.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	121.61	53.71	3.40	47.22	0.31	1.85	6.17	0.00	12.66
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	272.18	59.70	5.27	87.80	0.00	0.00	12.29	0.00	24.58
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	270.31	34.57	6.29	72.29	0.00	0.00	12.57	0.00	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	257.99	47.98	1.39	63.28	0.00	0.70	10.43	0.70	12.52
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	88.52	24.34	4.43	33.20	0.00	0.00	2.21	0.00	8.85
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	110.23	9.73	3.24	19.45	0.00	0.00	6.48	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	92.42	25.29	2.62	20.05	1.74	1.74	4.36	0.00	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	89.99	24.75	6.75	42.75	0.00	0.00	0.00	0.00	11.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	80.15	13.94	0.00	20.91	0.00	0.00	10.45	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	80.01	18.14	4.27	19.20	0.00	5.33	3.20	2.13	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	166.25	31.87	1.39	34.64	0.00	4.16	8.31	0.00	12.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	290.66	28.50	2.85	51.29	0.00	0.00	5.70	0.00	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	162.92	30.37	0.92	35.90	0.00	0.92	12.89	0.00	9.20
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	60.51	15.13	0.00	24.20	0.00	3.03	3.03	0.00	12.10
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	105.55	18.63	12.42	31.04	6.21	0.00	0.00	0.00	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	57.10	17.98	5.29	11.63	0.00	4.23	1.06	0.00	5.29
Keratinocyte - epidermal, donor1	11272-116H3	48.47	8.00	4.16	2.69	0.16	1.80	2.94	0.08	0.73
Keratinocyte - epidermal, donor2	11349-117G8	24.60	1.17	3.51	1.76	1.17	0.00	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	21.11	3.60	2.56	2.27	0.95	1.99	0.85	0.47	0.28
Keratinocyte - oral, donor1	11251-116E9	45.86	5.11	4.54	1.70	1.59	5.11	1.59	1.02	0.68
Keratocytes, donor1	11527-119I6	61.20	11.69	8.25	15.47	1.38	1.03	2.06	2.06	2.06
Keratocytes, donor2	11607-120I5	14.06	7.03	1.17	5.86	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	13.63	2.96	4.54	0.99	1.19	1.19	0.40	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	2.20	4.40	4.40	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	8.63	0.00	1.08	0.00	0.00	0.00	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	17.42	4.50	6.00	2.31	4.50	1.38	0.12	0.92	0.00
Lens Epithelial Cells, donor3	11690-122I7	18.06	3.94	9.99	1.82	0.81	2.72	0.71	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	15.53	5.10	5.22	3.08	0.95	0.83	0.47	0.36	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.26	6.42	1.95	1.67	0.28	0.28	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.22	6.93	6.14	1.42	0.63	0.47	0.63	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.84	4.30	5.91	2.69	0.54	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.25	5.99	4.41	2.21	0.00	0.32	1.26	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.41	10.03	4.85	2.26	0.11	0.65	0.22	0.11	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.16	6.98	3.69	1.64	0.82	0.41	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.57	5.56	3.29	2.28	0.00	0.51	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.02	5.63	7.32	1.97	0.56	0.84	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	6.33	3.96	2.37	0.40	0.00	1.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.59	7.37	4.07	2.52	0.78	0.39	0.58	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.33	5.55	5.18	1.11	1.11	1.30	0.37	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.36	4.18	4.53	1.39	1.05	1.39	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.72	6.92	4.05	1.19	0.48	0.48	0.72	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.30	6.59	4.81	2.06	0.27	0.55	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.24	6.78	5.54	1.23	0.62	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.86	6.55	3.74	1.25	0.31	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.06	9.15	4.76	2.74	1.10	1.28	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.54	4.94	2.30	2.96	0.33	1.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.37	9.66	4.98	2.64	0.29	0.29	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.70	8.71	7.47	0.25	0.25	1.00	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	4.36	3.39	1.45	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.46	5.66	3.23	2.42	0.27	0.81	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.66	8.63	4.54	1.21	0.45	1.06	0.30	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	5.70	4.67	1.04	0.00	1.04	0.52	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.23	6.28	3.77	1.47	0.21	1.05	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.57	7.67	6.62	2.11	0.75	0.15	0.45	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	6.88	4.82	4.13	0.69	0.69	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.83	6.59	5.08	2.63	0.19	0.94	0.19	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.16	8.16	7.53	2.65	0.53	0.85	0.42	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.57	5.33	3.39	3.39	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.62	4.63	6.28	1.98	0.33	1.32	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.42	9.91	7.56	1.24	0.37	0.87	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.11	4.07	7.40	2.22	0.74	1.48	1.11	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.19	7.91	3.46	1.48	0.25	0.74	0.25	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.39	6.46	6.19	2.34	0.41	0.27	0.41	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.54	3.54	4.82	1.93	0.64	0.00	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.56	7.61	5.48	0.91	0.00	0.91	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.10	6.86	4.48	1.96	0.56	0.56	0.56	0.14	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.47	5.33	4.62	2.84	0.00	0.71	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	6.79	5.33	2.42	0.00	0.00	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.80	10.27	9.34	2.65	0.31	0.93	0.31	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.89	5.73	3.22	2.86	0.36	1.07	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.53	6.53	4.25	2.29	0.65	1.31	0.65	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.77	6.83	7.77	2.35	0.94	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.56	4.21	5.20	2.23	0.25	0.99	0.74	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.12	7.94	4.61	1.28	0.26	0.77	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.16	6.56	8.95	2.39	1.79	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	6.80	6.80	6.80	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	13.04	6.90	12.27	0.00	3.07	2.30	0.00	4.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	6.68	8.16	6.68	0.00	0.74	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.58	20.31	7.62	18.62	0.85	2.96	0.85	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.03	11.96	8.44	14.07	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	8.41	10.27	4.67	12.14	0.93	2.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	14.94	7.73	6.18	0.52	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	16.65	9.52	13.08	0.00	0.00	0.00	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.92	12.21	4.52	8.60	0.45	1.13	1.13	1.13	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.69	18.90	3.20	8.14	1.16	1.45	0.87	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	6.30	15.31	7.20	7.20	1.35	2.25	0.00	1.35	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.08	14.09	7.86	10.30	0.00	2.30	0.81	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.22	14.89	8.22	16.43	0.51	0.51	1.03	0.00	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.70	12.70	4.59	11.29	0.71	1.41	0.35	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	6.66	2.67	7.33	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.21	22.92	9.17	13.75	0.51	2.04	1.02	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	6.94	12.54	7.20	6.94	0.80	1.07	0.80	1.07	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.39	17.19	6.99	11.90	0.57	1.13	0.57	0.76	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.75	21.47	6.14	11.66	0.61	1.23	1.23	0.00	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7.34	13.86	6.52	15.49	1.63	0.00	1.63	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	6.66	11.66	6.04	9.16	0.42	0.62	0.83	0.42	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.53	19.34	5.61	13.17	1.12	1.12	0.00	0.28	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	10.30	10.30	7.21	11.33	0.00	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.19	20.03	8.13	9.00	0.87	1.45	1.45	0.58	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	19.13	9.27	8.97	0.60	0.30	0.00	0.30	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	7.75	12.17	6.64	11.07	0.00	1.66	0.00	1.66	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.14	25.80	10.96	14.85	1.06	2.83	1.41	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	9.22	25.81	5.53	15.49	0.00	0.37	2.21	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	8.06	3.45	10.36	1.15	2.30	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.98	14.20	7.68	9.21	0.00	1.54	1.92	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	21.51	9.62	7.93	0.00	1.70	0.57	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	20.51	4.92	12.31	0.82	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	10.85	18.08	8.59	10.85	0.45	0.45	2.26	0.45	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	6.46	17.24	3.59	6.46	0.72	5.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	6.72	8.22	5.98	9.71	0.00	2.24	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.38	19.69	7.80	9.29	1.86	1.49	1.11	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.89	14.21	3.88	8.18	0.00	0.86	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	7.71	11.13	9.42	12.84	0.86	0.86	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	15.33	8.00	11.66	0.00	0.33	0.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	15.08	6.03	14.48	1.81	1.81	1.21	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	9.24	7.82	11.38	0.71	2.84	1.42	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.94	17.53	7.91	11.00	0.00	1.72	0.69	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	11.27	9.66	4.29	10.73	0.00	1.61	1.07	1.61	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	12.79	5.39	10.77	0.67	1.35	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.26	22.22	8.52	11.48	0.74	2.22	1.85	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	12.79	1.16	1.16	0.00	3.49	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	9.52	6.35	12.69	2.12	0.00	2.12	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.00	16.41	9.20	11.60	0.00	1.20	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	18.17	5.09	8.72	0.00	2.18	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	13.03	11.50	9.96	0.00	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	7.89	17.76	8.39	16.28	0.00	1.97	1.97	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	10.35	9.41	16.94	0.94	0.94	1.88	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.05	11.56	9.05	13.07	0.00	2.51	0.00	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.97	17.12	6.76	14.42	0.00	0.90	0.00	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	13.77	10.33	13.77	0.00	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	9.35	17.37	8.02	15.14	1.34	1.78	0.45	0.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.56	20.33	8.99	15.25	0.39	1.96	0.39	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.24	13.85	5.28	10.56	0.66	0.66	0.66	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.34	12.97	8.82	17.12	0.00	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6.56	24.07	7.00	7.44	0.00	1.31	1.31	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	9.50	15.10	10.62	13.98	0.00	1.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.39	22.08	6.18	15.46	0.00	0.44	0.00	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.87	13.89	10.80	11.19	0.00	0.77	0.39	0.39	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.17	18.23	7.60	7.60	1.01	1.52	0.51	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.05	14.90	5.29	13.46	0.00	0.96	0.48	0.00	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.53	21.87	9.54	9.54	0.40	1.19	0.80	1.19	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.94	23.09	7.29	17.62	0.00	1.82	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	13.83	7.61	16.60	0.00	0.00	0.00	0.00	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.82	23.18	9.50	12.54	0.38	0.76	0.00	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.94	24.79	9.30	18.07	0.00	0.52	1.03	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	17.53	10.88	5.44	12.70	0.60	0.60	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.09	21.23	4.44	12.04	0.32	1.90	0.32	1.58	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.99	19.72	9.06	16.53	0.53	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.84	15.52	4.02	18.39	0.57	0.00	0.57	0.57	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	15.43	20.06	7.71	19.54	1.03	1.03	1.03	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.85	17.68	8.49	6.37	0.00	1.41	0.71	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.19	18.73	2.27	13.05	0.57	0.00	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	21.63	7.49	14.98	1.25	1.66	1.66	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	12.53	17.23	4.70	14.09	0.00	1.57	1.57	0.00	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.45	16.28	2.09	12.11	0.42	2.51	1.25	1.25	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.05	22.30	6.04	12.08	0.00	1.86	0.46	0.93	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	11.37	10.70	12.71	0.00	2.01	1.34	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.92	16.04	5.88	10.16	1.60	2.14	0.53	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.34	16.97	4.85	10.51	0.40	1.21	0.40	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	20.19	8.26	11.01	0.00	1.84	4.59	0.92	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	13.34	7.11	17.78	0.00	2.67	0.00	0.89	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.36	16.53	4.56	14.82	0.00	1.14	0.00	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	9.20	7.67	8.44	0.00	0.77	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.32	19.15	2.19	15.87	0.00	1.09	0.55	0.55	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.48	16.04	6.24	15.59	0.00	1.78	1.34	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.14	13.78	3.90	8.32	0.52	1.04	0.78	1.04	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.23	14.59	7.29	21.88	1.33	0.66	1.33	0.66	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	47.81	4.16	14.55	2.08	2.08	0.00	0.00	4.16
Macrophage - monocyte derived, donor1	11232-116C8	6.61	2.05	1.37	1.82	0.23	0.68	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	5.32	2.02	1.10	2.57	0.55	0.55	0.55	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	9.70	3.15	0.66	2.88	0.66	0.52	0.52	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.34	2.66	0.53	0.53	0.00	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	15.05	2.54	3.96	2.06	0.79	1.43	1.11	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	18.35	2.64	1.67	4.03	0.28	1.39	0.97	0.28	1.11
Mammary Epithelial Cell, donor1	11273-116H4	24.71	8.37	3.89	3.49	0.50	2.39	1.40	0.90	0.30
Mammary Epithelial Cell, donor2	11350-117G9	24.03	3.47	2.03	1.74	1.16	2.32	1.16	0.87	0.87
Mammary Epithelial Cell, donor3	11422-118F9	10.97	2.49	2.24	2.99	0.00	1.00	0.00	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	3.39	5.42	8.14	0.00	0.00	1.36	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	3.57	8.65	9.41	2.81	1.41	3.24	0.32	0.87	0.22
Mast cell, donor2	11565-120D8	2.67	10.70	17.24	2.08	1.49	6.54	0.30	1.19	0.00
Mast cell, donor3	11566-120D9	3.15	9.46	16.21	2.03	1.80	4.95	0.23	1.58	0.00
Mast cell, donor4	11567-120E1	2.13	12.59	14.36	2.84	1.06	8.16	0.18	0.89	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	11.98	6.43	4.99	4.32	0.55	1.77	0.00	0.22	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	15.76	5.25	2.33	0.58	1.17	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	8.49	6.08	6.88	4.82	0.57	2.41	0.00	0.23	0.00
Mast cell, expanded, donor8	11941-126A6	3.85	9.71	10.71	3.35	1.17	3.35	0.17	1.34	0.17
Melanocyte - dark, donor1	11502-119F8	7.16	3.78	3.58	3.08	0.90	0.30	0.00	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	5.54	3.11	2.77	1.38	0.00	1.04	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	42.45	4.78	5.22	2.97	2.25	1.01	1.96	0.72	0.07
Melanocyte - light, donor1	11274-116H5	29.38	4.70	4.70	2.59	1.18	1.88	1.18	0.00	0.47
Melanocyte - light, donor2	11351-117H1	19.11	6.82	3.41	2.73	2.73	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	12.14	6.07	2.60	1.73	1.73	0.87	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	41.34	2.92	1.77	2.71	1.35	0.21	1.98	0.00	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	21.78	5.11	4.57	2.69	1.61	0.54	2.96	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	34.82	8.30	7.50	2.14	3.21	1.87	1.87	0.54	0.27
Meningeal Cells, donor1	11493-119E8	52.11	9.55	3.72	4.84	0.50	0.99	2.48	0.12	0.99
Meningeal Cells, donor2	11573-120E7	34.77	5.72	3.96	3.96	1.32	0.44	0.44	0.00	2.20
Meningeal Cells, donor3	11654-122E7	25.02	5.79	2.93	3.83	0.57	0.41	1.06	0.00	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	10.27	3.14	1.14	1.14	0.86	1.71	0.29	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.59	4.43	3.52	2.11	0.40	0.40	0.60	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	1.31	14.46	1.31	1.31	2.63	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	19.62	1.31	3.92	3.92	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	2.87	0.72	1.44	0.00	1.44	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.19	4.66	5.93	2.54	0.85	0.85	1.06	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	4.02	4.02	4.52	0.50	2.01	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.98	4.83	2.20	4.83	0.22	0.44	1.10	0.00	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.19	6.58	2.19	7.31	0.73	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	24.14	3.27	1.43	2.86	0.82	0.41	0.61	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.39	3.05	4.43	0.28	1.11	1.80	0.00	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	21.93	4.83	5.95	4.09	2.23	1.86	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	10.66	4.08	4.61	1.32	1.32	2.24	0.00	0.39	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.01	6.23	12.46	3.56	1.48	2.08	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	11.68	9.34	0.00	0.00	4.67	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.29	5.12	0.64	3.84	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	22.68	3.54	0.00	2.13	0.35	1.42	1.77	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	6.25	3.13	4.69	0.94	1.56	2.50	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	11.61	2.18	1.45	3.63	0.00	0.00	1.45	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	16.18	5.83	3.71	2.92	0.27	1.59	0.00	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	6.51	2.50	2.00	0.50	0.00	0.00	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	10.48	5.71	2.96	4.62	0.51	0.94	0.79	0.58	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	5.40	2.70	4.05	4.05	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.16	2.71	0.99	2.46	0.74	0.49	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	5.30	2.65	0.59	1.47	0.59	0.59	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.82	3.10	0.62	2.48	0.31	0.93	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.98	3.32	0.62	1.66	0.00	0.83	0.41	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	5.01	5.01	1.50	4.00	0.50	2.75	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	5.12	0.93	2.79	0.47	0.93	0.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.66	3.66	1.02	2.44	0.61	0.41	0.20	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.96	3.17	0.79	1.58	0.40	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	0.88	0.00	0.88	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.18	4.94	0.38	1.90	0.00	0.38	1.14	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.49	6.58	1.06	4.88	0.21	0.21	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	1.84	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.79	4.47	1.49	4.77	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	5.03	3.35	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.01	3.76	1.51	3.51	0.00	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.61	4.75	1.43	0.95	0.48	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	4.98	0.55	3.87	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.84	2.76	0.92	3.45	0.00	0.46	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.94	2.31	1.05	1.05	0.42	0.63	0.84	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2.04	2.24	1.43	3.47	0.20	0.41	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	2.36	3.43	0.64	2.57	0.21	1.29	0.43	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	3.78	2.89	0.67	1.78	0.22	0.67	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.41	3.29	2.19	4.38	0.22	0.00	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	2.53	1.01	2.53	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	6.63	1.66	1.66	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.36	5.44	1.63	4.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.35	2.94	1.76	4.12	0.29	0.00	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	6.54	0.00	3.27	0.00	1.09	0.00	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	2.88	1.92	1.92	0.00	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.60	5.60	0.80	2.00	0.00	1.20	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	5.48	2.74	1.37	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	1.50	1.00	2.00	0.50	1.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	2.04	2.04	6.12	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	4.38	0.44	5.26	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.64	3.84	1.28	1.92	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.99	6.20	1.74	4.71	0.00	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	2.09	2.78	4.18	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	2.21	8.84	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.42	5.13	1.71	2.74	0.00	0.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.88	2.19	1.75	2.19	0.44	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.49	3.91	1.07	5.68	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.09	7.57	1.96	5.05	0.00	1.12	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	2.49	3.33	2.08	0.42	0.42	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	6.99	2.33	2.91	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.92	4.83	0.90	2.11	0.00	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.68	4.17	2.50	1.25	0.00	0.00	1.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	4.62	2.77	5.54	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	2.28	2.85	3.98	0.57	0.57	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.70	1.93	2.07	3.73	0.41	0.69	0.14	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.77	5.96	1.04	2.59	0.52	0.78	0.78	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	4.29	4.29	1.29	5.58	0.86	0.43	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.91	1.27	3.81	2.54	1.91	0.64	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.47	3.47	1.33	2.40	0.53	0.27	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4.49	3.59	2.39	5.69	0.60	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.26	3.53	0.99	3.53	0.71	0.71	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.50	5.41	2.23	4.78	0.32	0.96	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.53	2.21	1.99	4.42	0.66	0.66	1.11	0.88	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.90	4.17	0.76	1.90	0.76	0.76	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.40	7.39	1.42	3.69	0.28	0.85	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	4.18	2.21	1.97	2.95	0.25	1.23	0.74	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.30	3.26	3.26	1.96	1.30	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	3.23	3.82	0.88	3.23	0.00	1.47	0.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.32	4.32	1.73	2.88	0.00	0.58	0.29	0.86	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	3.71	7.01	1.65	1.24	0.41	3.30	0.00	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.36	3.87	1.79	2.38	0.30	2.68	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	4.93	2.96	0.66	1.97	0.33	0.33	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	3.16	0.00	2.10	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.77	4.55	0.40	1.78	0.40	0.79	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	6.52	0.00	2.79	0.93	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	2.25	3.76	0.38	2.25	0.38	0.75	0.75	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.53	1.86	0.27	1.07	0.27	1.33	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.52	1.24	0.45	1.24	0.23	0.79	0.45	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	2.21	2.21	4.42	0.74	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.40	5.13	0.00	1.10	0.37	0.37	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	4.67	0.00	4.67	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	0.53	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	4.04	1.01	2.02	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.53	0.42	0.00	0.84	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.81	0.00	0.81	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	3.02	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00	3.26	0.00	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	4.75	4.75	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	11.85	2.15	3.02	2.59	0.43	0.65	0.00	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.45	6.27	6.27	1.57	0.00	1.57	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.69	13.35	8.01	15.35	0.00	0.67	2.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	14.19	17.53	7.51	9.60	1.25	0.42	0.83	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	28.14	22.06	3.61	8.18	1.14	1.14	1.71	0.19	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	15.96	12.77	30.32	3.19	0.00	3.19	0.00	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	20.40	8.84	11.56	7.48	0.00	0.68	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	130.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.09	10.88	13.81	7.12	1.67	0.84	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.53	8.83	7.44	4.65	0.46	0.70	0.70	0.23	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.65	11.89	11.35	6.22	0.27	0.81	0.54	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.46	11.14	11.56	7.36	0.21	0.63	0.21	0.00	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	1247.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	10.92	12.91	2.48	0.00	0.50	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.50	11.64	6.23	2.44	0.81	1.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.67	6.57	8.84	3.85	0.45	1.59	0.23	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.29	8.98	9.31	5.39	0.49	0.33	0.00	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	12.39	8.57	6.74	5.65	1.28	2.19	0.73	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.67	12.20	13.26	9.02	0.53	2.12	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	14.41	13.81	3.60	0.60	0.60	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.14	28.55	7.22	2.30	1.31	0.98	0.98	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.90	8.13	10.08	4.72	0.81	0.65	0.16	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.17	9.00	12.35	7.41	0.53	1.59	0.53	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	9.14	11.95	4.22	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.44	12.41	12.87	4.14	0.00	0.46	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.75	8.03	8.68	9.32	0.64	1.29	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	5.86	20.69	6.90	1.72	2.76	3.10	0.34	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	465.23	0.00	5.06	0.00	2.53	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.47	11.36	10.47	6.91	0.45	0.89	0.67	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.28	12.70	12.70	5.93	0.42	0.85	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.12	11.87	9.02	4.75	0.71	1.19	0.24	0.47	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.30	7.73	11.59	9.44	0.00	2.15	1.29	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	1751.39	0.00	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.66	9.66	13.66	4.00	1.00	1.00	0.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	16.68	9.92	10.37	0.45	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.14	7.14	5.95	6.75	0.40	1.19	0.00	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	11.14	11.14	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.78	12.49	5.68	4.54	1.51	2.27	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.47	4.24	7.17	8.80	0.98	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	12.64	13.51	8.72	0.87	0.00	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	8.59	7.69	11.76	0.45	0.90	0.90	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	7.06	8.82	7.94	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	13.30	11.30	7.98	0.00	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	11.91	14.39	11.91	1.49	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.27	10.72	9.57	10.34	0.77	0.77	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.10	13.01	11.49	4.54	2.12	2.12	0.60	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.40	6.19	9.95	6.19	0.44	1.33	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	12.20	8.13	4.74	1.36	0.68	0.00	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	357.67	0.00	5.11	0.00	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	10.36	10.36	7.93	0.61	1.83	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.41	11.65	7.55	7.87	0.31	0.94	0.63	1.57	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.38	16.04	16.65	8.17	0.30	0.91	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	14.24	13.45	10.28	0.00	2.37	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	57.82	5.67	2.27	2.27	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	273.13	5.06	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.80	3.98	2.86	1.61	0.25	1.37	0.75	0.12	0.12
Myoblast, donor2	11322-117D8	14.77	6.33	4.03	2.88	0.58	2.49	0.96	0.38	0.00
Myoblast, donor3	11398-118D3	20.01	4.20	2.86	3.87	1.18	1.01	1.35	0.34	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	30.65	4.82	1.17	5.55	0.15	0.15	0.88	0.00	0.58
Natural Killer Cells, donor1	11230-116C6	8.92	4.92	14.76	0.62	0.31	0.31	0.00	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	6.94	12.06	14.17	3.92	0.30	0.90	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	6.81	6.26	18.41	4.23	0.74	0.55	0.18	0.00	0.00
Neural stem cells, donor1	11275-116H6	52.99	11.61	19.24	3.27	0.73	1.81	0.73	0.00	0.36
Neural stem cells, donor2	11352-117H2	38.51	3.85	23.11	1.93	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	35.27	17.07	23.90	5.69	4.55	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	50.86	22.02	14.53	5.28	2.42	2.20	0.88	0.44	0.00
Neurons, donor3	11655-122E8	21.38	32.89	29.60	20.55	2.47	1.64	2.47	0.00	0.82
Neutrophils, donor1	11233-116C9	0.00	3.71	10.21	1.86	0.93	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	5.80	5.80	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	3.67	7.94	0.61	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	3.32	5.11	9.62	0.95	1.19	4.27	0.12	0.47	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	3.58	6.19	13.68	0.65	1.63	1.63	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.02	4.81	3.01	1.60	0.60	1.40	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	5.23	11.29	11.15	6.19	0.69	0.96	0.00	0.41	0.41
Olfactory epithelial cells, donor2	11934-125I8	6.37	15.05	10.71	6.22	1.01	2.61	0.58	0.29	1.45
Olfactory epithelial cells, donor3	11935-125I9	6.02	12.94	11.01	4.54	1.59	1.59	0.11	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	13.93	15.39	13.34	6.04	2.24	4.19	0.58	0.10	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	21.67	1.20	2.41	3.61	1.81	3.01	0.60	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.21	7.02	8.30	2.55	1.28	4.68	0.85	1.28	1.06
Osteoblast - differentiated, donor2	11353-117H3	5.72	4.57	5.72	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	2.48	4.97	5.59	0.00	2.48	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	14.07	7.82	3.52	4.10	0.59	1.76	0.59	0.00	0.78
Osteoblast, donor2	11354-117H4	14.75	2.11	2.11	4.92	0.70	1.40	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	11.91	2.67	5.51	3.73	1.07	2.49	0.36	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	12.89	4.80	2.86	3.45	0.34	3.29	0.51	0.34	0.51
Pericytes, donor1	11491-119E6	12.68	6.90	9.24	2.00	3.00	1.89	0.56	0.45	0.11
Pericytes, donor2	11571-120E5	16.52	12.68	16.30	3.17	2.94	0.23	0.45	0.45	0.45
Pericytes, donor3	11652-122E5	10.58	5.49	1.83	2.44	0.61	1.22	0.61	0.00	1.02
Perineurial Cells, donor1	11499-119F5	16.84	5.99	2.60	4.07	2.15	1.81	0.11	0.23	0.34
Perineurial Cells, donor2	11579-120F4	8.93	3.59	3.59	2.21	0.46	1.75	0.46	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	9.88	6.69	7.97	1.27	0.64	1.27	0.64	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	5.63	4.90	8.08	3.18	0.00	0.24	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	4.92	3.75	7.89	2.85	0.00	0.78	0.13	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	22.00	5.02	3.83	4.07	0.24	0.96	0.48	0.24	0.96
Placental Epithelial Cells, donor2	11355-117H5	9.98	5.54	4.44	2.22	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	8.64	3.73	6.68	2.75	0.20	2.55	0.00	0.98	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.23	4.43	7.28	3.16	2.53	0.95	0.32	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	9.94	8.07	10.13	1.88	0.56	2.06	0.56	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.32	13.44	14.36	7.83	0.26	1.70	0.91	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	11.26	10.13	8.56	3.83	1.13	0.90	0.00	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	11.72	5.75	7.35	1.70	0.64	2.34	0.75	0.21	0.21
Preadipocyte - omental, donor2	11329-117E6	10.91	7.86	10.04	4.36	0.87	1.31	0.00	0.00	1.31
Preadipocyte - omental, donor3	11403-118D8	15.90	6.73	6.45	3.58	1.29	1.15	0.57	0.14	0.43
Preadipocyte - perirenal, donor1	11469-119C2	2.95	2.95	5.91	6.89	0.98	3.94	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.35	2.46	2.76	3.99	0.92	2.15	0.92	1.23	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	30.28	12.75	3.19	4.25	0.89	1.59	0.71	0.53	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	13.96	4.09	4.60	2.38	1.02	1.87	0.85	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	29.81	7.36	2.79	3.73	0.47	1.86	0.93	0.00	0.47
Preadipocyte - visceral, donor2	11357-117H7	12.42	6.44	0.00	3.68	0.00	1.38	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	14.73	6.16	2.72	2.93	0.63	0.73	0.42	0.31	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	38.17	6.34	2.11	3.02	0.30	0.91	1.36	0.00	0.30
Prostate Epithelial Cells, donor2	11331-117E8	17.06	5.55	5.82	2.71	0.27	2.17	1.62	0.00	0.68
Prostate Epithelial Cells, donor3	11404-118D9	15.74	2.88	2.33	1.41	0.67	0.43	0.73	0.43	0.12
Prostate Stromal Cells, donor1	11254-116F3	15.60	3.76	3.30	3.53	0.34	0.91	0.57	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	15.42	10.22	3.77	3.77	0.18	1.79	1.08	0.00	0.90
Prostate Stromal Cells, donor3	11405-118E1	6.57	4.28	5.94	2.40	0.31	1.25	0.21	0.31	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.02	3.65	4.74	7.30	2.19	0.36	1.09	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	19.62	4.51	2.84	1.73	1.80	1.18	0.69	0.35	0.21
Renal Epithelial Cells, donor1	11517-119H5	35.00	7.61	5.58	6.09	1.01	1.52	2.03	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	24.90	10.67	6.40	5.69	0.00	0.71	1.42	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	24.88	8.15	4.76	2.75	3.28	1.59	0.21	0.32	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	6.13	2.72	4.09	0.68	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	19.27	5.53	1.48	3.91	0.40	0.27	0.81	0.27	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.31	6.88	3.33	4.22	0.22	1.11	0.67	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.96	10.65	3.99	0.00	0.00	0.67	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	26.85	4.84	4.84	5.72	1.10	0.66	1.54	0.22	1.54
Renal Mesangial Cells, donor2	11598-120H5	18.18	4.39	6.27	0.63	2.51	1.25	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	14.98	9.71	7.49	1.11	1.39	0.83	1.39	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	43.22	8.05	3.22	8.05	0.81	0.54	2.95	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	19.82	6.33	4.64	4.64	0.00	0.00	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	21.02	9.64	2.89	5.01	1.93	0.77	1.54	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.96	3.11	1.56	1.56	1.56	0.78	0.52	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	34.39	4.55	9.66	5.12	1.14	1.14	1.71	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	30.87	5.15	4.12	6.17	0.00	2.06	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.33	3.01	4.01	1.51	0.50	1.51	1.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	5.48	8.02	4.68	3.61	0.94	2.94	0.00	1.07	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	3.57	11.61	16.97	0.89	1.79	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	43.48	12.66	3.30	19.81	0.00	0.55	3.30	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.26	8.70	9.28	18.56	1.16	0.58	1.74	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.24	14.30	2.21	14.04	0.26	0.00	1.43	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.82	13.31	1.79	11.12	0.60	1.19	0.60	0.20	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	40.04	14.05	2.01	10.04	0.22	0.22	3.23	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.75	9.30	1.74	6.20	0.12	0.25	1.36	0.37	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	25.29	14.57	2.68	11.30	0.35	0.47	1.05	0.12	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	36.75	15.25	3.47	11.79	0.23	0.69	1.39	0.00	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	24.64	13.28	2.88	7.67	0.27	0.27	0.82	0.68	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.95	9.83	2.27	10.59	0.15	0.76	1.51	0.15	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	29.39	15.05	3.23	11.65	0.54	0.90	0.90	0.18	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.97	9.76	2.01	8.75	0.29	0.29	1.29	0.14	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	25.11	10.62	3.22	9.87	0.32	0.32	0.97	0.11	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.65	13.72	3.54	15.27	0.22	0.66	0.89	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.96	9.94	2.87	8.22	0.19	0.38	0.38	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.92	9.69	1.86	9.88	0.37	0.28	1.30	0.09	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	40.02	10.15	1.50	9.21	0.38	0.19	2.63	0.00	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.96	10.88	2.79	7.17	0.66	0.13	1.59	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	23.26	8.96	2.04	9.34	0.19	0.49	0.88	0.10	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	33.23	16.04	4.77	10.69	0.76	0.00	2.29	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.96	9.50	2.99	6.09	0.75	0.32	1.17	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.02	15.70	2.52	11.77	0.00	0.84	2.24	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	29.91	13.67	2.39	7.69	0.17	0.51	1.37	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	24.43	12.95	1.82	9.48	0.36	0.18	1.46	0.18	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.20	13.24	2.70	8.83	0.61	0.00	1.84	0.00	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	28.21	10.21	3.36	7.92	0.54	0.13	1.34	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	30.19	13.21	3.07	9.43	0.24	0.71	1.65	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	26.59	14.09	5.95	8.73	0.40	0.60	0.79	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	35.08	14.03	3.98	12.63	0.47	0.23	1.64	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	24.05	10.37	2.07	7.46	0.83	0.00	0.83	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	28.09	12.83	3.76	9.51	0.44	0.88	1.33	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.07	16.50	5.22	10.65	0.00	0.00	1.46	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	30.95	10.09	3.36	7.67	0.00	0.13	1.21	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	22.31	12.43	5.11	10.73	0.00	0.17	1.36	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	34.12	13.11	2.12	13.69	0.96	0.19	0.96	0.19	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	32.32	12.55	2.92	6.53	0.17	0.69	1.55	0.00	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.04	12.89	3.98	11.25	0.55	0.41	1.10	0.27	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.65	12.81	4.10	10.84	0.66	0.49	1.31	0.16	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.86	8.86	2.39	7.50	0.51	0.00	0.85	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.64	10.06	2.81	10.36	0.44	0.59	1.18	0.44	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.92	8.53	3.47	6.93	0.53	0.27	0.80	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.78	9.26	2.77	7.05	0.41	0.83	0.97	0.14	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.05	6.67	2.62	7.14	0.48	0.48	0.71	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	29.43	11.69	3.63	9.88	1.41	1.01	1.81	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	19.12	9.61	3.11	6.78	0.66	0.47	1.13	0.19	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	17.47	9.43	5.24	5.94	0.00	0.35	1.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.69	10.58	4.84	8.16	0.00	0.60	1.21	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.21	12.24	3.43	5.63	0.24	0.61	0.73	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	32.89	17.76	10.77	16.01	1.46	1.16	1.02	0.29	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.34	10.95	6.69	8.52	0.61	1.22	1.22	0.00	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	21.40	9.95	5.12	4.22	0.30	0.30	0.60	0.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	28.05	14.25	7.92	7.46	0.90	0.45	1.36	0.90	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	25.76	19.17	14.08	9.59	2.10	1.50	1.20	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	28.46	10.39	4.72	5.43	0.94	0.71	0.71	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.63	10.67	10.03	8.75	0.43	1.92	0.64	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.04	15.02	13.82	10.82	2.40	1.20	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	23.70	8.84	4.70	4.70	1.88	1.13	1.13	0.19	0.38
Schwann Cells, donor2	11578-120F3	10.21	3.40	0.00	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.36	7.23	4.16	2.41	1.31	0.88	0.44	0.22	0.44
Sebocyte, donor1	11220-116B5	50.39	5.48	2.19	1.10	0.55	2.74	1.64	0.00	0.00
Sebocyte, donor2	11301-117B5	33.09	7.35	1.38	2.30	0.00	0.92	1.84	0.46	0.00
Sebocyte, donor3	11378-118B1	20.82	3.92	3.50	1.24	0.82	0.62	1.03	0.41	0.00
Sertoli Cells, donor1	11255-116F4	16.57	1.66	9.94	4.97	0.00	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	8.47	14.12	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	36.33	7.13	5.01	2.11	1.32	2.20	1.23	0.53	0.26
Skeletal Muscle Cells, donor2	11358-117H8	6.51	5.06	4.34	2.17	1.45	4.34	0.72	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.97	7.52	3.34	5.02	0.84	3.34	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	20.11	5.81	3.14	4.40	0.31	0.94	0.63	0.00	0.63
Skeletal Muscle Cells, donor5	11455-119A6	21.55	6.69	3.57	4.01	0.45	0.74	0.74	0.15	0.74
Skeletal Muscle Cells, donor6	11459-119B1	29.86	5.08	2.00	3.85	0.92	0.46	1.08	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.63	4.79	4.54	2.52	1.13	2.27	0.63	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.84	3.14	5.14	2.28	1.14	1.85	0.14	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.99	5.16	1.88	3.67	0.99	0.60	0.69	0.20	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.16	9.69	5.90	4.72	1.35	2.61	0.34	0.51	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.85	7.24	3.62	4.34	0.00	2.17	2.17	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.39	4.68	5.92	2.48	0.55	1.79	0.55	0.28	0.28
Skin - palm, donor1	10286-104F7	10.74	42.98	80.58	2.69	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.28	2.74	1.73	0.86	0.00	0.58	0.86	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	193.02	7.36	11.45	11.45	0.00	1.64	5.73	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	21.29	2.99	3.12	2.99	0.13	0.91	2.47	0.13	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	19.04	4.03	1.95	1.25	0.70	0.97	1.81	0.42	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	13.36	5.20	4.22	2.39	0.98	1.69	0.42	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	131.52	15.65	8.25	7.82	1.27	5.07	4.86	0.63	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	10.49	4.87	3.00	2.92	0.97	1.20	0.75	0.45	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.71	4.63	4.63	0.62	0.93	1.85	0.31	1.85	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.78	6.67	8.00	2.89	0.89	2.45	2.00	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	5.88	2.35	4.70	0.59	4.11	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.92	12.82	7.29	3.54	1.10	0.44	1.33	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.54	3.94	3.15	7.48	0.79	0.79	0.39	0.39	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	16.22	7.73	4.64	6.18	1.55	2.32	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	9.01	11.01	3.00	0.00	5.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.11	5.72	3.59	3.46	0.93	1.46	1.06	0.40	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.96	5.76	4.43	1.11	1.11	1.33	0.22	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.11	2.94	3.58	1.54	0.26	1.15	0.13	0.51	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	8.79	4.88	3.58	0.33	1.30	0.33	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.83	4.13	2.36	4.73	0.89	1.18	1.77	0.00	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.40	3.27	1.99	1.99	0.43	1.00	0.28	0.00	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	50.10	4.23	1.95	5.21	0.00	0.98	2.28	0.65	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.96	3.96	10.05	0.61	1.22	1.52	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.84	5.81	6.06	3.03	1.01	2.78	1.01	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	12.24	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.63	1.91	3.81	2.86	0.48	1.91	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.32	3.39	3.10	1.62	0.00	0.59	0.44	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	7.75	3.66	3.44	1.51	0.22	0.65	0.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.49	2.73	3.04	2.10	0.21	0.31	0.42	0.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	22.12	4.02	2.63	6.03	0.93	1.70	0.93	0.31	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	3.23	11.86	0.00	0.00	4.31	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.94	3.89	2.39	0.90	1.49	0.90	1.79	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	28.34	4.78	3.41	9.56	0.34	0.68	0.68	0.34	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	7.93	4.48	5.58	1.57	1.65	2.75	0.00	0.47	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.77	4.93	4.33	0.91	0.81	2.62	0.50	0.81	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.43	7.96	5.01	2.28	0.91	1.37	0.68	1.14	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.08	6.64	3.02	1.21	1.21	3.62	0.00	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	34.18	7.42	1.59	6.09	0.53	0.53	1.32	0.00	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.52	6.39	3.86	3.06	0.27	1.33	0.80	0.27	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	6.39	4.38	3.88	0.88	0.88	0.50	0.00	0.25	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.03	1.78	4.31	0.76	0.00	1.01	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.20	4.52	3.32	1.81	1.06	1.36	1.36	0.45	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.75	3.00	9.00	0.75	0.75	4.50	0.75	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	83.99	131.81	1.29	1.29	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	23.25	5.58	6.05	4.19	3.26	4.65	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	8.08	6.06	0.00	0.50	3.53	1.01	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.72	4.70	4.70	1.25	0.63	1.57	0.31	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	3.24	4.42	2.06	0.00	0.88	0.88	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	18.41	3.17	1.33	2.00	0.75	1.25	0.50	0.33	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	5.14	3.27	5.14	2.34	0.93	0.93	0.47	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.09	4.03	4.32	5.32	1.30	2.73	0.29	0.00	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.53	4.84	4.08	4.33	1.02	1.02	1.27	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.24	6.96	5.08	5.64	0.94	0.75	0.94	0.38	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	14.67	2.66	1.54	1.82	0.98	0.28	0.14	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.97	2.43	2.26	1.42	0.59	1.01	0.08	0.34	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	15.24	3.33	0.95	0.95	0.95	0.00	0.95	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.72	4.40	3.67	2.69	1.22	1.47	0.73	0.24	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	19.66	6.63	4.20	2.43	0.44	1.33	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	13.75	6.73	1.76	5.56	0.29	1.46	1.17	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	3.89	6.41	8.94	3.50	0.97	3.30	0.00	0.00	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.05	6.08	6.35	2.91	0.53	2.12	0.79	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.39	5.58	7.07	5.21	0.00	1.86	0.74	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.53	5.39	6.83	4.67	0.36	2.16	0.72	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	19.87	3.41	5.39	4.26	0.28	2.27	0.57	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.96	6.30	3.54	9.06	1.18	0.79	1.18	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	9.65	5.08	7.62	3.30	1.02	2.54	0.51	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.19	5.99	10.78	2.80	0.00	2.40	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	7.94	3.34	5.43	4.18	0.42	2.51	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	2.29	6.42	5.50	3.67	0.46	1.38	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	4.54	6.40	5.55	2.19	1.01	1.85	0.00	0.34	0.67
Synoviocyte, donor2	11368-117I9	3.35	3.69	5.20	3.69	1.17	1.84	0.17	0.84	0.34
Synoviocyte, donor3	11440-118H9	4.69	7.37	8.27	1.56	1.56	2.01	0.22	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	38.23	5.72	3.93	8.22	0.36	0.71	1.43	0.00	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	3.96	3.96	3.96	0.00	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	20.84	7.87	6.25	4.40	0.93	0.93	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	24.66	4.80	1.00	3.94	1.00	1.51	0.93	0.43	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	14.30	2.32	4.25	2.71	0.39	2.71	0.77	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	21.19	5.15	2.86	1.72	0.57	0.57	0.00	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	5.41	8.49	3.81	3.44	0.74	2.34	0.25	0.86	0.12
Urethra, donor2	10319-105A4	14.39	17.98	25.18	7.19	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	37.72	6.11	2.39	6.38	0.27	1.59	1.59	0.27	0.27
Urothelial Cells, donor2	11600-120H7	31.24	5.21	2.00	2.00	0.00	0.80	2.40	0.00	0.80
Urothelial Cells, donor3	11681-122H7	26.59	5.27	2.52	2.75	0.46	1.38	0.69	0.23	0.23
Urothelial cells, donor0	11216-116B1	26.08	4.68	2.67	1.56	3.12	4.46	0.89	0.45	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	4.45	12.46	3.56	3.56	0.89	5.34	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	11.44	15.73	4.29	2.86	0.00	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.11	4.79	4.79	4.11	0.00	2.05	0.00	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	11.36	7.58	5.85	5.51	0.34	1.38	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	11.62	6.39	5.23	3.49	0.00	1.16	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	4.16	6.25	3.12	2.08	1.04	0.00	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	16.52	4.59	1.84	6.42	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	8.22	7.30	2.74	4.56	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	35.16	7.03	3.58	8.14	0.25	1.23	0.99	0.00	0.49
Wilms' tumor cell line:HFWT	10597-108E3	20.24	4.40	6.16	6.16	1.76	0.00	0.00	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	33.52	24.58	2.23	17.04	0.28	0.56	3.07	0.00	2.23
achilles tendon, donor2	10292-104G4	2.07	10.33	20.67	4.13	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	67.05	5.35	0.76	11.73	0.00	0.25	4.59	0.00	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	89.39	17.41	3.25	17.88	0.70	0.46	2.79	0.00	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	57.45	20.30	16.14	10.21	0.47	0.36	1.78	0.00	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	92.52	11.16	5.71	12.79	0.54	1.09	2.72	0.00	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	73.93	5.06	1.12	2.53	0.28	0.00	2.53	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	31.09	3.38	2.54	2.54	0.42	0.21	1.06	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	50.09	5.44	8.17	3.81	0.27	0.54	2.99	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	46.27	4.85	1.32	7.49	0.44	0.00	3.53	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	49.00	3.27	1.63	3.68	0.41	0.00	2.45	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	72.22	8.54	2.72	9.32	0.78	0.39	3.88	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	74.70	6.07	0.74	2.94	0.37	0.00	6.62	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	35.10	3.90	7.80	0.00	0.00	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	48.57	5.81	2.09	4.88	0.70	0.46	1.63	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	103.56	12.43	3.37	5.95	0.00	0.00	7.25	0.00	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	54.65	4.97	1.17	3.51	0.29	0.29	4.09	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	9.30	5.58	1.86	4.18	0.00	0.93	1.39	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	40.30	9.46	0.82	8.64	1.23	0.00	6.17	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.06	6.14	0.61	15.65	0.00	0.31	0.31	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	24.32	4.69	0.43	6.40	0.43	0.43	0.85	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.75	5.16	0.00	5.46	0.00	0.00	2.12	0.30	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	22.87	6.02	0.24	5.54	0.48	0.48	2.41	0.00	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	46.55	6.01	0.22	4.01	0.00	0.22	2.67	0.00	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	29.69	9.67	2.67	9.67	0.67	0.00	0.67	0.67	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	81.76	13.01	7.43	13.01	1.86	0.00	3.72	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	56.88	7.91	2.26	11.68	0.75	0.38	1.51	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.10	7.85	8.72	4.36	0.87	0.00	3.05	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	18.74	13.12	11.25	3.75	5.62	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	40.98	8.01	9.89	6.36	0.47	0.24	1.88	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	11.32	9.15	10.86	3.26	1.24	3.57	0.31	1.55	0.31
adipose, donor1	10184-103D4	24.63	50.43	10.56	9.38	2.93	0.00	1.76	0.00	0.00
adipose, donor2	10185-103D5	15.41	36.50	23.52	12.57	2.43	0.41	0.41	0.00	0.41
adipose, donor3	10186-103D6	21.51	21.24	15.79	11.71	2.72	0.54	0.27	0.54	0.82
adipose, donor4	10187-103D7	20.80	41.60	22.54	7.80	2.60	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.24	7.89	3.95	9.00	0.95	0.47	1.26	0.00	1.58
adrenal gland, adult, pool1	10081-102A9	3.64	7.28	10.91	3.64	3.64	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	31.35	8.94	2.00	4.00	0.53	0.27	0.93	0.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	35.73	9.29	2.14	11.43	0.36	0.00	2.50	0.00	1.43
amniotic membrane cells, donor1	12235-129G3	12.52	8.11	5.56	3.25	0.93	3.48	0.23	2.09	0.23
amniotic membrane cells, donor2	12236-129G4	6.76	9.13	8.79	6.42	0.00	2.03	1.01	1.01	0.34
amniotic membrane cells, donor3	12237-129G5	7.07	6.78	7.07	1.47	1.47	4.71	0.00	0.88	0.59
amygdala - adult, donor10196	10167-103B5	16.60	24.90	46.25	1.19	15.42	4.74	1.19	3.56	0.00
amygdala, adult, donor10252	10151-102I7	14.80	31.63	58.60	5.68	24.74	7.71	0.00	4.87	0.20
amygdala, newborn, donor10223	10360-105E9	19.04	19.04	36.80	3.55	6.13	1.61	0.00	0.32	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	15.15	7.64	10.70	2.04	0.51	0.38	0.38	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	56.04	9.93	6.62	11.25	0.66	0.44	3.31	0.44	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	80.17	10.02	14.36	8.35	5.68	3.01	0.67	0.33	0.00
aorta, adult, pool1	10052-101G7	4.71	20.99	42.56	4.31	1.96	4.51	0.00	2.16	0.20
appendix, adult	10189-103D9	11.64	8.54	10.87	5.05	0.78	1.16	0.39	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.86	7.22	3.10	5.16	1.03	0.69	1.03	0.69	0.34
artery, adult	10190-103E1	5.43	4.08	13.59	1.36	1.36	2.72	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	16.51	8.69	8.55	3.33	0.29	0.58	0.72	0.58	0.00
b cell line:RPMI1788	10427-106D4	34.94	7.88	3.12	3.27	0.45	1.04	1.78	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.05	5.27	6.38	6.66	0.00	0.83	1.11	0.55	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	19.05	7.14	2.38	4.07	0.00	0.30	0.79	0.00	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	10.88	1.84	0.67	4.02	0.00	0.17	0.17	0.00	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	28.52	16.22	8.39	10.07	1.12	0.56	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	6.30	14.78	23.79	2.28	1.74	7.39	0.00	0.87	0.00
blood, adult, pool1	10053-101G8	2.21	6.64	6.64	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	7.71	8.56	4.28	9.42	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	9.45	7.42	7.42	2.70	0.67	2.70	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	6.15	33.83	37.93	10.25	15.38	5.13	0.00	2.05	1.03
brain, adult, pool1	10012-101C3	12.58	21.94	38.75	3.12	18.26	7.91	0.11	3.45	0.00
brain, fetal, pool1	10085-102B4	40.07	72.13	85.48	13.36	18.70	2.67	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	10.90	19.16	8.26	12.55	0.33	0.99	0.66	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.33	11.98	6.62	8.86	0.75	6.37	1.50	1.75	0.75
breast, adult, donor1	10080-102A8	10.73	5.68	4.42	3.79	1.26	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.41	6.22	1.52	9.40	0.13	0.38	2.67	0.00	2.16
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	21.34	11.44	3.09	10.51	0.31	1.86	0.31	0.62	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	35.91	13.12	4.14	3.22	0.00	0.00	0.69	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.95	15.25	7.99	9.93	0.24	1.45	1.21	0.97	0.48
carcinoid cell line:NCI-H1770	10703-109H1	97.79	19.28	15.05	17.87	0.94	0.47	4.70	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	22.53	8.20	3.06	8.09	0.77	0.44	0.98	0.22	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	67.50	15.21	10.14	6.34	0.63	0.00	1.27	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	63.35	38.06	27.42	16.50	2.66	0.80	0.80	0.00	1.06
caudate nucleus - adult, donor10196	10177-103C6	11.51	14.97	40.30	5.76	12.66	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	14.56	18.91	43.84	4.18	25.94	7.03	0.17	4.35	0.00
caudate nucleus, adult, donor10258	10379-105H1	10.70	21.40	36.68	5.35	20.63	3.82	0.00	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	28.20	16.11	19.78	6.23	7.69	1.83	0.73	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	11.65	11.65	55.35	5.83	8.74	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	14.95	30.53	40.57	8.11	19.86	5.34	0.21	1.71	0.21
cerebellum, adult, pool1	10083-102B2	8.28	18.97	32.77	5.52	19.32	3.45	0.34	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	22.42	40.68	39.85	17.44	8.30	1.66	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	4.29	23.45	37.82	3.28	9.58	5.80	0.25	1.76	0.00
cerebrospinal fluid, donor2	10294-104G6	5.12	5.12	13.16	6.58	0.73	1.46	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	50.18	4.74	1.58	4.74	0.29	0.14	2.16	0.00	0.72
cervical cancer cell line:ME-180	10553-107I4	18.39	9.78	4.97	8.95	0.50	0.83	0.83	0.50	0.83
cervix, adult, pool1	10013-101C4	11.23	14.80	19.21	4.30	2.94	7.66	0.10	2.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	1.81	19.51	6.69	12.40	1.25	2.37	0.00	0.70	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	6.53	9.14	3.92	3.92	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	27.34	4.10	1.74	3.11	0.37	0.37	0.99	0.12	0.75
choriocarcinoma cell line:SCH	10785-110H2	18.36	10.47	5.17	10.47	0.74	2.09	0.49	0.12	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	13.28	4.03	1.19	3.08	0.00	0.00	1.19	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	5.41	4.27	2.28	1.14	0.85	2.56	0.00	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	13.82	6.26	4.18	5.57	1.19	2.78	1.39	0.60	0.20
chorionic membrane cells, donor3	12240-129G8	4.40	6.04	5.49	3.30	0.00	2.20	0.55	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	23.23	8.08	11.11	2.02	0.00	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	38.04	9.80	5.57	8.84	0.96	0.96	1.92	0.19	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	37.59	5.91	7.81	5.91	0.84	0.21	2.53	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	46.99	8.99	0.77	5.39	0.26	1.03	2.31	0.26	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	54.42	8.95	1.45	8.47	0.24	0.24	1.21	0.00	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	51.11	8.55	1.22	8.55	0.00	0.20	1.22	0.20	3.05
chronic myelogenous leukemia cell line:K562	10454-106G4	162.54	15.61	0.29	16.78	0.29	0.00	3.83	0.00	7.95
chronic myelogenous leukemia cell line:KU812	10409-106B4	89.92	9.90	2.87	7.04	1.04	1.30	3.91	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.54	5.26	1.60	3.20	0.23	0.23	0.91	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	37.30	14.57	2.95	16.83	0.17	0.87	2.08	0.35	1.21
colon carcinoma cell line:CACO-2	10513-107D9	33.13	10.98	3.84	13.00	0.00	0.92	1.46	0.00	1.46
colon carcinoma cell line:COLO-320	10420-106C6	71.84	6.46	0.76	6.08	0.76	0.38	1.52	0.00	1.14
colon, adult, donor1	10082-102B1	19.04	21.42	16.66	8.33	1.19	4.76	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	11.28	9.64	10.69	3.53	2.00	4.94	0.47	0.82	0.00
colon, fetal, donor1	10070-101I7	3.71	13.60	16.07	4.33	2.47	1.24	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	105.42	0.00	4.58	9.17	0.00	0.00	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	86.69	36.97	3.40	24.22	0.00	0.00	5.10	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	102.78	18.11	0.91	12.68	0.15	0.60	3.62	0.00	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	103.36	21.01	1.13	13.11	0.00	0.28	4.23	0.14	1.41
corpus callosum, adult, pool1	10042-101F6	14.48	27.31	27.42	4.53	15.04	11.17	0.11	4.31	0.11
cruciate ligament, donor2	10295-104G7	2.43	10.54	16.21	3.24	0.81	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	3.21	11.24	13.64	5.62	0.00	0.80	0.00	0.80	0.00
diencephalon, adult	10193-103E4	6.48	15.36	21.84	3.12	11.04	2.40	0.00	2.16	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	95.75	10.10	3.67	4.82	0.23	0.46	3.67	0.00	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	15.64	7.44	1.03	4.87	0.51	0.00	0.26	0.00	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	41.40	5.06	5.78	1.93	0.00	0.24	1.93	0.00	0.24
ductus deferens, adult	10196-103E7	9.97	14.95	9.47	1.99	1.99	6.48	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	4.32	20.16	14.40	8.64	0.00	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	8.09	13.24	18.39	3.68	2.94	3.68	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	8.67	10.82	23.54	1.65	1.98	4.05	0.50	0.33	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	153.23	162.78	15.32	119.92	1.78	3.55	5.33	0.89	15.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	55.88	32.81	4.16	20.92	0.57	0.29	2.01	0.00	4.30
embryonic pancreas cell line:1B2C6	10604-108F1	14.80	6.17	0.00	8.63	0.62	0.62	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	32.39	3.03	0.30	5.45	0.30	0.00	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.71	4.63	0.00	6.48	0.93	0.00	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	24.96	3.94	1.31	10.51	3.94	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	19.78	6.70	1.34	6.37	0.67	0.34	0.67	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	34.62	10.33	3.26	9.79	0.72	1.09	0.54	0.00	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	0.96	9.49	4.18	6.75	0.96	0.80	0.00	0.64	0.64
epidermoid carcinoma cell line:A431	10426-106D3	16.34	4.45	2.11	2.45	0.67	0.56	0.44	0.44	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	37.18	7.04	1.43	4.62	0.55	0.22	2.42	0.00	0.55
epididymis, adult	10197-103E8	6.07	13.40	15.70	2.30	2.30	3.14	0.21	0.21	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.26	7.45	1.95	8.34	1.06	0.89	0.18	0.18	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	71.57	11.40	3.54	11.80	0.39	0.39	3.15	0.00	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	50.72	11.79	0.26	8.91	0.26	0.13	1.70	0.00	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	41.53	9.15	0.39	6.00	0.20	0.20	1.38	0.00	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	43.36	9.07	0.78	5.83	0.11	0.00	1.79	0.00	1.12
esophagus, adult, pool1	10015-101C6	11.89	9.45	9.13	4.57	1.17	4.88	0.00	0.96	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	59.74	8.77	7.89	3.88	2.50	1.50	1.63	0.13	0.63
eye - muscle inferior rectus, donor1	10272-104E2	7.24	28.97	28.97	4.83	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	2.10	8.42	6.31	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	2.98	11.91	17.86	10.42	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	1.15	14.90	14.90	5.73	1.15	3.44	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	14.57	21.86	2.91	1.46	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	5.85	13.47	14.49	15.51	5.08	3.05	0.00	1.27	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	0.00	6.92	7.95	7.44	1.28	1.28	0.00	0.51	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	38.94	13.77	3.32	13.53	0.47	0.24	1.66	0.47	1.90
frontal lobe, adult, pool1	10040-101F4	19.98	23.36	49.91	2.81	19.80	7.98	0.19	3.38	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.81	13.21	2.40	14.71	0.00	1.20	0.90	0.00	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	13.81	6.22	2.83	7.13	0.18	0.18	0.00	0.09	0.64
gall bladder, adult	10198-103E9	7.48	11.35	14.00	1.93	2.17	2.90	0.00	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	11.81	9.66	4.29	5.37	0.00	1.07	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	8.59	6.35	5.60	4.11	0.37	1.12	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	31.26	11.19	9.93	5.49	0.84	0.63	2.11	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	56.86	3.48	2.32	3.67	0.39	0.39	1.16	0.19	0.77
gastric cancer cell line:AZ521	10549-107H9	48.20	10.66	2.30	12.13	0.82	0.98	2.30	0.00	1.31
gastric cancer cell line:GSS	10560-108A2	38.44	4.58	0.00	7.32	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	45.01	10.51	5.25	10.74	2.51	0.46	0.69	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	47.50	1.95	0.46	2.18	0.00	0.00	0.92	0.00	1.61
giant cell carcinoma cell line:Lu99B	10433-106E1	16.80	4.76	3.92	2.52	0.42	1.12	0.28	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	4.99	5.99	2.74	4.24	0.50	1.25	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	4.12	17.21	2.01	15.94	0.74	1.79	0.21	0.32	1.79
glioblastoma cell line:A172, tech_rep2	10444-106F3	3.09	13.20	1.69	28.65	1.40	1.69	0.14	0.00	2.39
glioblastoma cell line:T98G	10485-107A8	15.23	6.07	6.51	6.73	0.22	0.66	0.88	0.44	0.44
glioma cell line:GI-1	10413-106B8	32.22	7.91	7.91	8.20	0.59	0.88	1.76	0.00	1.17
globus pallidus - adult, donor10196	10175-103C4	8.75	17.49	33.53	6.56	6.56	5.10	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	20.02	23.19	30.76	4.88	14.40	7.08	0.00	4.15	0.00
globus pallidus, adult, donor10258	10367-105F7	9.58	17.80	34.23	15.06	10.95	9.58	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	12.79	20.25	17.05	6.93	6.40	2.13	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	105.23	14.68	0.00	7.34	0.00	0.00	17.13	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.12	11.84	6.08	8.32	1.28	1.92	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	45.91	5.51	5.97	7.35	0.46	0.00	2.30	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	45.73	0.91	1.37	9.15	0.46	0.00	0.91	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	52.82	2.58	4.51	15.46	0.00	0.64	1.93	0.00	0.00
hIPS, biol_rep1	14380-156B6	51.74	1.44	4.31	1.44	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	49.38	2.74	2.74	10.29	0.00	0.00	1.37	0.00	1.37
hIPS, biol_rep3	14382-156B8	13.24	11.03	25.38	7.72	6.62	5.52	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	54.88	6.61	3.16	6.03	0.57	0.57	3.16	0.29	0.00
heart - mitral valve, adult	10205-103F7	4.78	11.06	14.95	3.29	3.29	1.79	0.00	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	5.49	14.90	20.13	2.61	2.61	4.71	0.00	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	31.64	2.50	3.33	3.33	0.00	2.50	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	12.86	10.81	11.22	10.00	2.24	1.63	0.20	1.84	0.00
heart, adult, diseased, donor1	10051-101G6	11.50	21.29	18.31	7.66	2.98	1.70	0.00	0.85	0.43
heart, adult, pool1	10016-101C7	7.36	8.97	5.29	4.60	4.14	3.22	0.23	0.92	0.69
heart, fetal, pool1	10046-101G1	13.04	10.99	15.61	4.31	3.80	4.52	0.00	1.03	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	5.24	9.87	8.64	8.64	2.47	3.39	0.00	1.54	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	13.08	1.19	7.14	2.38	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	78.45	7.40	1.10	8.73	0.22	0.11	2.98	0.00	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	76.71	6.68	2.06	6.43	0.36	0.49	3.88	0.12	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	79.63	7.17	1.52	5.76	0.10	0.40	4.14	0.10	0.51
hepatoma cell line:Li-7	10484-107A7	26.25	4.67	2.45	4.67	0.22	0.33	0.67	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	35.78	3.62	0.60	2.61	0.20	0.10	1.71	0.10	0.70
hippocampus - adult, donor10196	10169-103B7	9.46	23.66	52.99	4.73	11.36	2.84	0.00	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	11.43	25.92	46.13	6.74	19.80	6.74	0.00	3.47	0.00
hippocampus, adult, donor10258	10374-105G5	12.45	15.44	42.82	3.98	7.47	5.48	0.00	3.49	0.00
hippocampus, newborn, donor10223	10363-105F3	20.80	26.08	41.24	4.23	9.52	1.06	0.70	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	91.55	14.65	1.83	7.93	2.44	0.00	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	49.87	10.01	0.39	6.09	1.18	0.00	0.79	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	49.76	7.11	1.52	11.17	1.27	0.00	2.03	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.88	10.71	14.10	9.59	3.95	0.56	2.82	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.95	17.30	9.04	7.23	2.58	1.03	0.77	0.00	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.14	15.94	10.63	4.93	2.28	0.76	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	29.78	17.52	20.73	7.01	1.75	0.29	0.58	0.00	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	38.13	18.74	21.97	8.40	1.29	0.22	0.86	0.00	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	42.96	17.10	19.19	14.18	1.25	0.00	0.42	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.20	9.47	9.47	6.39	0.47	0.00	0.71	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.50	20.89	10.61	10.77	0.96	1.29	0.64	0.16	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	32.99	13.47	11.45	9.43	0.00	0.67	1.35	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	57.43	12.68	1.56	8.61	0.63	0.00	2.19	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	59.94	11.79	0.49	13.76	0.00	0.00	1.97	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	92.51	18.33	0.87	10.47	0.00	0.00	2.62	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	33.60	22.53	16.61	13.75	0.95	0.76	0.95	0.19	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	26.60	16.57	13.95	16.57	1.74	0.00	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	27.99	20.49	17.99	7.50	4.00	1.50	0.50	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.96	13.19	30.90	5.84	2.07	2.07	0.57	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	18.64	14.55	25.46	10.91	2.73	2.27	0.45	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	17.23	17.85	24.43	7.52	1.25	0.94	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.23	15.19	16.98	9.96	2.29	1.47	0.49	0.33	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.64	13.93	18.58	7.84	2.03	1.45	1.16	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	24.21	14.95	14.35	5.98	2.69	0.60	0.90	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	51.54	12.01	1.29	6.47	0.55	0.00	2.03	0.18	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	52.21	13.12	1.43	9.70	0.86	0.86	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	72.68	13.47	2.45	8.17	0.00	0.41	2.45	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	24.29	11.62	10.21	10.56	1.41	1.41	0.35	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	20.27	12.04	6.65	8.55	0.95	0.63	1.90	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	24.51	14.22	8.78	6.36	0.30	0.91	0.30	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	24.30	16.55	20.17	9.31	1.03	0.52	0.00	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.25	16.60	20.59	7.31	3.32	0.00	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.40	8.72	21.55	4.62	0.77	0.51	0.26	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	32.47	8.18	10.23	7.67	0.77	1.02	1.02	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	34.83	12.12	19.69	10.60	0.76	0.76	1.51	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.59	15.12	13.11	9.75	2.02	0.67	1.34	0.00	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	65.21	12.32	1.21	9.18	0.24	0.48	1.21	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	59.72	12.92	1.34	5.35	0.45	0.45	1.78	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	60.49	12.20	0.00	9.76	0.00	0.00	1.95	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	35.76	11.92	8.25	8.56	3.36	0.00	0.92	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	120.37	35.79	13.01	6.51	0.00	0.00	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	42.69	13.57	8.27	11.58	2.32	1.65	2.32	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	41.05	12.59	21.34	9.30	1.09	0.55	1.64	0.00	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	27.87	14.11	18.09	5.79	1.09	0.72	1.09	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.27	10.68	9.61	5.69	1.78	1.78	0.71	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	47.74	16.71	14.32	11.93	0.00	1.19	2.39	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	42.25	10.43	12.59	8.67	1.76	1.08	0.68	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	31.79	15.89	11.58	6.47	0.27	1.35	1.08	0.00	0.54
immature langerhans cells, donor1	11904-125F5	6.54	1.94	6.05	1.70	0.24	0.24	2.91	0.00	0.00
immature langerhans cells, donor2	11905-125F6	8.71	17.43	20.60	3.17	0.00	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	26.50	28.20	58.96	4.54	24.32	9.18	0.38	3.60	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	15.93	4.23	4.23	4.88	0.33	0.33	0.65	0.33	1.30
kidney, adult, pool1	10017-101C8	13.02	8.91	7.61	3.90	2.10	4.71	0.40	0.70	0.10
kidney, fetal, pool1	10045-101F9	17.05	14.01	17.83	7.92	2.33	4.95	0.78	1.34	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	33.80	9.09	17.18	4.69	0.43	0.99	1.14	0.28	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.87	2.07	0.55	2.90	0.14	0.41	0.41	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.19	8.99	3.67	5.87	1.65	0.55	0.18	0.18	0.73
left atrium, adult, donor1	10079-102A7	4.36	10.90	12.53	4.36	3.81	2.72	0.00	1.09	0.00
left ventricle, adult, donor1	10078-102A6	6.57	14.16	17.19	3.54	2.02	1.52	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	40.77	9.85	5.75	11.49	0.00	0.00	1.09	0.00	2.74
leiomyoma cell line:10964C	10569-108B2	11.86	5.39	5.03	1.80	0.36	1.80	0.72	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	9.24	5.98	3.26	0.00	0.00	0.00	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	8.98	5.34	5.58	0.97	0.73	1.94	0.00	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	12.70	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	32.41	31.37	10.46	11.50	0.00	0.00	6.27	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	87.72	8.97	10.63	6.97	0.59	0.94	6.97	0.47	0.59
liposarcoma cell line:KMLS-1	10782-110G8	16.71	8.59	10.15	7.81	0.31	0.94	1.25	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	12.18	6.34	4.39	5.24	1.46	0.49	0.61	0.24	0.61
liver, adult, pool1	10018-101C9	7.78	7.45	1.62	5.19	0.49	2.43	0.00	0.81	0.32
liver, fetal, pool1	10086-102B5	8.47	4.70	0.94	5.64	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	6.71	26.54	33.39	6.12	12.40	3.65	0.29	2.04	0.00
locus coeruleus, adult, donor10252	10165-103B3	12.73	20.49	23.99	3.51	13.10	5.91	0.00	3.51	0.18
locus coeruleus, adult, donor10258	10375-105G6	8.18	20.60	34.42	6.77	7.62	5.36	0.00	2.54	0.56
locus coeruleus, newborn, donor10223	10362-105F2	30.71	11.78	13.46	2.94	3.36	2.94	0.42	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	9.13	1.80	0.42	1.94	0.14	0.00	0.28	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	27.58	11.72	2.76	5.52	0.00	2.76	2.76	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	14.76	5.54	2.37	5.01	0.53	1.19	0.92	0.26	0.40
lung, adult, pool1	10019-101D1	5.20	7.91	9.10	2.84	1.65	4.49	0.12	0.59	0.00
lung, fetal, donor1	10068-101I5	13.13	13.41	11.70	4.85	2.57	4.57	0.29	1.43	0.29
lung, right lower lobe, adult, donor1	10075-102A3	3.67	15.12	13.29	4.58	1.83	2.75	0.00	0.92	0.00
lymph node, adult, donor1	10077-102A5	9.47	8.52	12.78	2.37	0.47	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	26.52	8.11	7.01	6.36	0.00	0.88	1.53	0.00	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	49.96	9.96	0.60	12.98	0.00	0.15	2.26	0.00	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	101.09	35.68	5.10	43.32	0.00	0.85	0.85	0.00	4.25
mature adipocyte, donor1	12231-129F8	5.33	12.43	9.77	2.66	0.44	4.44	0.00	2.22	0.00
mature adipocyte, donor2	12232-129F9	7.89	11.41	10.38	4.77	0.62	2.28	0.42	0.62	0.00
mature adipocyte, donor3	12233-129G1	5.45	7.82	10.67	4.74	0.47	3.08	0.00	0.71	0.00
mature adipocyte, donor4	12234-129G2	4.74	9.74	11.06	3.16	0.53	4.21	0.00	1.58	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	43.12	10.25	1.67	9.77	0.48	0.71	0.95	0.00	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	21.43	16.92	48.51	3.38	15.79	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	13.43	27.03	50.02	6.44	21.88	7.54	0.00	2.57	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	11.75	27.64	47.02	5.08	12.71	4.13	0.00	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	32.84	23.88	36.68	2.56	8.96	0.85	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	15.36	45.56	71.38	4.05	16.20	6.41	0.17	1.52	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	16.77	33.74	58.36	6.79	21.65	6.79	0.00	4.46	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	11.56	34.67	1.93	5.78	0.00	0.00	5.78	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	459.32	0.00	14.35	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	24.77	40.92	56.71	4.31	13.64	2.15	0.36	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	7.14	20.77	22.71	5.19	7.14	5.19	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	12.38	13.16	23.68	6.19	9.44	6.35	0.31	2.01	0.15
medulla oblongata, adult, pool1	10038-101F2	13.47	16.16	26.37	3.18	12.90	7.59	0.33	3.92	0.16
medulla oblongata, newborn, donor10223	10361-105F1	16.66	13.19	14.23	6.25	3.82	2.08	0.35	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	110.26	17.05	21.03	9.30	1.77	2.66	2.44	0.44	0.89
medulloblastoma cell line:ONS-76	10759-110E3	60.04	5.99	2.45	9.90	1.22	0.86	2.69	0.12	1.22
melanoma cell line:COLO 679	10514-107E1	26.88	3.59	3.45	3.45	0.57	0.29	2.30	0.14	0.57
melanoma cell line:G-361	10465-106H6	48.05	5.43	3.80	2.99	1.09	0.27	3.80	0.27	1.36
meningioma cell line:HKBMM	10691-109F7	19.90	4.34	3.80	1.81	1.09	0.72	0.72	0.54	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	106.62	31.72	39.65	17.62	3.52	0.88	1.76	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	97.47	30.85	25.92	12.18	1.81	0.52	1.81	0.26	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.58	3.38	2.30	1.69	0.31	0.61	0.46	0.15	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.73	3.64	3.27	0.55	0.36	1.27	0.55	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	10.35	4.97	3.73	0.41	0.41	0.00	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.87	3.51	1.97	0.56	0.84	0.98	0.70	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.09	4.81	3.27	1.54	0.58	1.16	0.39	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	5.55	2.78	3.47	2.08	0.69	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.55	1.37	1.89	0.34	0.00	0.34	0.69	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.12	3.22	2.65	0.58	0.23	0.46	0.58	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.82	1.86	1.72	1.06	0.53	0.27	0.27	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.61	4.19	2.30	0.54	0.00	0.27	0.95	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.51	2.13	1.14	2.13	0.43	1.00	0.85	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.21	6.92	4.61	2.63	0.33	0.33	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.96	3.46	3.04	1.94	0.69	0.28	1.11	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.36	5.93	3.49	2.44	0.35	1.75	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.96	2.65	1.63	0.41	0.82	0.82	0.61	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.06	7.19	5.75	3.24	0.36	1.08	1.08	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.62	4.34	2.59	1.76	0.93	0.83	0.21	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.38	7.07	4.56	3.88	0.46	0.68	0.68	0.00	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	19.30	3.78	2.52	1.26	0.42	0.00	1.26	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.30	3.14	3.89	1.20	0.60	1.05	0.45	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	6.83	2.80	2.10	1.31	0.44	0.35	0.26	0.44	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	11.04	5.52	5.15	2.58	0.74	1.84	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	6.30	5.72	3.15	0.00	1.14	0.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	17.26	14.31	5.47	5.47	0.42	0.84	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.94	5.48	5.02	2.74	0.00	0.00	0.00	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.21	4.09	4.60	3.07	0.51	0.77	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.85	4.97	8.38	2.09	0.52	0.26	0.52	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.09	5.85	8.32	0.31	0.62	0.62	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.59	4.71	4.00	0.71	0.47	0.71	0.71	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	7.78	4.74	6.09	1.02	0.34	1.02	0.00	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.29	4.72	6.29	0.79	0.79	1.57	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.27	4.63	5.56	0.46	0.46	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	5.19	5.19	5.19	2.60	1.44	0.87	0.29	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.81	5.80	3.79	2.01	0.89	0.67	0.22	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.69	4.09	6.97	1.68	0.00	0.72	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	4.40	5.13	8.07	1.47	1.47	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	3.69	3.02	6.71	1.01	0.00	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.60	4.91	7.78	0.41	0.41	0.82	0.00	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.01	4.73	3.01	1.72	0.43	0.86	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	16.41	0.00	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	5.16	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.50	6.50	5.52	1.30	0.65	0.65	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	8.73	11.64	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.00	7.46	8.00	2.13	0.00	0.00	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	3.27	4.91	3.27	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.83	3.11	5.05	1.17	0.00	0.78	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	8.39	4.20	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	4.97	5.96	1.99	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	6.52	4.74	3.56	2.37	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	9.75	4.87	1.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	3.80	5.07	3.17	0.00	1.27	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.69	8.28	8.28	2.41	0.34	0.34	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	4.30	10.75	4.30	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	7.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.15	6.52	8.96	3.26	0.41	2.04	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	10.33	6.36	7.94	1.59	1.59	1.59	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	16.51	4.72	4.72	1.77	0.59	1.77	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	11.22	4.36	9.04	1.87	0.31	0.94	0.31	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	4.01	16.04	0.00	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	26.02	7.10	9.46	2.37	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	2.57	17.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	2.75	6.88	3.44	0.00	1.38	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	18.80	9.90	6.93	2.97	0.00	1.48	0.49	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	10.09	6.73	3.36	1.12	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.99	8.27	6.36	4.45	0.00	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.46	9.67	4.03	4.03	1.21	2.82	0.81	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	15.26	2.18	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	10.14	5.07	6.34	0.00	5.07	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.64	6.68	5.46	5.46	0.61	1.82	0.00	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	22.59	4.52	4.52	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.94	11.53	3.29	5.77	0.00	1.65	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.50	9.92	5.56	3.97	0.20	0.99	0.40	0.40	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.03	8.44	9.73	4.87	0.32	1.95	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	11.20	6.11	7.13	2.04	3.06	0.00	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	10.06	6.96	5.42	0.77	3.09	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	20.79	15.59	0.94	18.66	0.94	0.47	1.42	0.00	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	5.79	8.80	3.94	12.05	0.93	0.46	0.23	0.70	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	25.64	0.00	12.82	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.73	8.43	5.75	11.82	0.92	2.98	1.34	0.41	0.62
mesothelioma cell line:Mero-25	10850-111F4	20.43	3.86	3.63	4.99	0.00	0.45	2.50	0.00	1.13
mesothelioma cell line:Mero-41	10851-111F5	20.29	9.53	7.82	6.36	0.00	0.49	0.98	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	7.53	4.43	4.21	3.10	0.89	1.55	0.44	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	22.34	10.51	5.78	8.94	1.58	2.10	0.79	0.00	1.05
mesothelioma cell line:Mero-83	10854-111F8	17.02	8.17	4.77	10.89	1.70	1.87	0.85	0.34	0.85
mesothelioma cell line:Mero-84	10855-111F9	13.14	10.36	3.03	9.10	0.51	0.76	0.76	0.25	1.52
mesothelioma cell line:Mero-95	10856-111G1	27.95	4.97	6.21	5.59	1.24	2.28	2.07	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	12.26	6.46	2.98	5.80	1.16	0.99	0.50	0.33	0.50
mesothelioma cell line:NCI-H226	10846-111E9	7.24	8.51	2.53	4.52	0.36	0.36	1.09	0.00	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	15.20	9.57	4.95	6.83	0.68	0.68	1.02	0.17	0.34
mesothelioma cell line:NCI-H28	10845-111E8	9.92	11.71	2.54	8.91	0.76	1.27	0.76	0.25	0.76
mesothelioma cell line:No36	10857-111G2	26.42	12.07	2.28	11.74	0.33	0.33	0.98	0.00	3.26
mesothelioma cell line:ONE58	10858-111G3	12.46	7.59	1.63	7.86	0.81	1.08	0.27	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	24.37	4.41	2.30	7.48	0.00	0.58	1.54	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	17.58	5.13	2.32	6.72	0.24	0.61	0.85	0.12	0.49
migratory langerhans cells, donor3	11903-125F4	17.95	4.31	4.31	5.03	0.72	0.54	1.26	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	27.10	10.45	3.92	3.59	1.96	0.00	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	4.45	2.54	1.06	2.54	0.21	0.00	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.06	9.21	1.84	10.14	0.69	0.46	0.46	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.41	9.51	3.43	8.94	0.57	1.52	1.14	0.95	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	81.68	8.69	0.18	5.91	0.00	0.18	4.62	0.18	0.18
myeloma cell line:PCM6	10474-106I6	53.37	5.34	5.14	2.17	0.20	0.20	1.19	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	35.51	4.57	3.55	5.07	1.01	1.01	0.00	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.79	12.55	8.43	10.98	0.39	1.18	0.59	0.59	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	23.51	5.13	1.23	1.67	0.11	0.33	0.67	0.56	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	20.00	3.31	1.40	1.91	0.15	0.22	0.74	0.15	0.37
nasal epithelial cells, donor2	12227-129F4	18.22	6.07	10.49	3.31	0.55	0.55	0.55	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	145.17	23.70	9.20	20.02	2.53	0.23	2.53	0.00	1.15
neuroblastoma cell line:NB-1	10539-107G8	107.95	17.21	8.98	15.72	0.56	1.12	5.24	0.37	2.25
neuroblastoma cell line:NBsusSR	10607-108F4	51.25	6.54	8.01	6.33	2.74	0.84	1.27	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	140.51	18.82	12.11	15.47	1.12	0.19	3.35	0.56	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	43.41	16.13	13.28	4.51	2.14	0.47	0.47	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	59.23	23.12	33.42	9.03	1.43	1.11	1.43	0.00	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	127.40	9.26	8.45	9.86	0.40	0.00	5.84	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	62.94	14.62	9.54	10.17	0.64	0.00	2.54	0.00	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	12.51	6.39	3.73	6.12	0.53	0.80	0.53	0.00	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	59.87	24.52	10.65	14.04	2.03	1.69	1.52	0.85	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	34.42	8.01	2.40	0.80	0.80	0.00	1.60	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	8.34	6.41	8.98	4.49	1.28	1.28	0.00	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.93	10.51	5.52	2.36	0.79	2.10	0.79	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	21.00	22.40	38.53	3.28	21.28	7.69	0.00	4.41	0.19
occipital cortex - adult, donor10196	10172-103C1	22.66	16.48	43.27	10.30	8.24	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	13.15	31.94	53.40	9.39	21.20	6.71	0.27	4.29	0.00
occipital cortex, newborn, donor10223	10355-105E4	24.75	37.12	47.31	4.73	12.37	2.91	0.36	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	8.13	35.42	57.47	3.67	13.38	3.41	0.52	1.31	0.00
occipital lobe, fetal, donor1	10073-102A1	48.49	75.95	102.55	14.16	9.87	1.29	0.86	0.86	0.00
occipital pole, adult, pool1	10036-101E9	18.84	22.31	42.18	2.37	21.37	9.70	0.32	4.97	0.32
olfactory region, adult	10195-103E6	11.08	30.57	50.63	3.44	16.81	6.69	0.00	2.48	0.00
optic nerve, donor1	10277-104E7	6.00	50.03	50.03	20.01	2.00	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	45.90	10.14	4.10	5.47	0.34	0.57	2.39	0.46	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	57.56	6.87	2.34	5.77	0.96	0.41	0.82	0.00	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	11.01	4.91	2.88	2.03	0.17	0.34	0.68	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.17	9.70	1.96	7.39	0.58	0.58	0.12	0.12	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	1.18	9.11	6.17	6.47	0.88	2.06	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	34.57	5.61	3.74	12.15	0.00	0.93	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	27.57	8.48	7.00	9.54	1.06	0.85	0.42	0.21	1.91
ovary, adult, pool1	10020-101D2	12.49	11.53	15.55	3.06	3.67	4.89	0.44	0.96	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.91	8.43	9.72	8.80	2.02	1.28	1.65	0.00	1.10
pancreas, adult, donor1	10049-101G4	13.17	10.35	2.82	9.41	0.00	2.82	2.82	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.41	8.67	1.12	6.99	0.84	0.00	1.40	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	11.24	7.33	3.07	3.92	0.00	0.00	1.02	0.00	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	16.39	4.97	2.81	4.97	0.50	0.83	0.83	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	18.95	18.95	38.99	3.57	20.96	7.50	0.64	4.03	0.27
parietal cortex, adult, donor10258	10373-105G4	16.15	18.35	36.70	4.40	8.07	5.87	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	10.35	23.51	43.26	5.64	15.99	4.70	0.00	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	13.40	30.21	50.74	4.85	16.82	6.27	0.00	3.99	0.00
parietal lobe, adult, pool1	10034-101E7	20.09	21.68	39.48	2.82	20.62	8.64	0.26	5.29	0.26
parietal lobe, fetal, donor1	10072-101I9	49.46	56.25	61.10	9.70	12.61	2.91	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	30.28	27.67	48.98	2.99	7.85	3.36	0.75	0.37	0.37
parotid gland, adult	10199-103F1	2.47	9.87	7.40	1.23	0.00	2.47	0.00	0.00	0.00
penis, adult	10200-103F2	10.21	12.89	20.95	1.61	1.61	6.45	0.00	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	70.28	9.67	7.07	4.83	2.60	2.23	0.93	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	8.01	7.14	2.33	5.54	0.29	0.00	0.44	0.15	0.44
pineal gland - adult, donor10196	10179-103C8	15.48	22.58	34.83	5.81	9.03	3.23	0.00	3.87	0.00
pineal gland, adult, donor10252	10160-103A7	30.20	13.03	24.28	10.66	22.50	7.70	0.59	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	18.81	25.08	31.98	1.25	6.90	10.03	0.00	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	8.09	16.19	11.13	7.08	9.11	2.02	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	19.28	14.59	7.30	17.72	6.25	11.47	0.00	1.56	2.08
pituitary gland, adult, donor10258	10378-105G9	16.17	14.47	11.92	4.26	3.40	5.96	0.00	0.85	0.85
placenta, adult, pool1	10021-101D3	6.34	11.93	6.67	8.82	1.61	3.33	0.43	0.97	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	36.55	7.28	1.19	7.28	0.13	0.13	1.06	0.00	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	2.65	7.78	3.89	8.09	0.47	1.56	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	11.96	10.33	23.58	3.79	16.09	8.52	0.09	3.01	0.26
postcentral gyrus, adult, pool1	10032-101E5	19.88	26.33	45.42	3.92	21.01	8.72	0.17	3.05	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	12.55	4.18	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.33	8.74	0.87	11.22	0.44	0.73	1.02	0.00	0.87
prostate cancer cell line:PC-3	10439-106E7	61.89	18.51	5.08	32.31	2.72	2.18	2.90	0.36	3.63
prostate, adult, pool1	10022-101D4	6.53	9.25	12.88	3.26	2.54	5.80	0.00	1.18	0.18
putamen, adult, donor10196	10176-103C5	15.11	21.48	39.19	4.01	23.84	8.03	0.00	5.43	0.24
putamen, adult, donor10252	10152-102I8	17.65	9.80	23.53	3.92	11.76	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	10.93	19.67	2.19	4.37	3.28	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	11.11	11.84	27.30	4.83	15.70	5.32	0.00	2.66	0.24
putamen, newborn, donor10223	10365-105F5	46.48	20.24	11.99	4.50	3.75	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	25.89	4.65	2.33	5.82	0.00	0.58	0.58	0.00	0.58
rectum, fetal, donor1	10067-101I4	12.52	38.95	50.08	6.95	5.56	5.56	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.57	11.45	2.12	5.72	0.00	0.00	0.42	0.00	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.02	15.33	11.18	5.80	0.41	4.56	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	12.62	16.60	22.76	3.48	5.37	11.03	0.10	2.19	0.20
retinoblastoma cell line:Y79	10475-106I7	124.96	11.95	10.39	11.17	0.78	0.26	6.24	0.26	2.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	42.91	10.94	3.81	8.98	2.70	0.74	2.46	0.25	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	72.27	17.72	7.87	21.65	0.00	0.84	2.53	0.00	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	2.27	5.30	14.40	4.55	2.27	2.27	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	27.68	4.86	8.42	3.24	0.97	1.46	0.81	0.49	0.16
salivary acinar cells, donor2	11772-123I8	23.96	9.64	16.66	2.62	0.96	3.17	1.38	0.55	0.00
salivary acinar cells, donor3	11773-123I9	9.93	15.89	33.10	3.31	0.00	7.94	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	6.29	14.87	9.72	4.58	1.14	4.58	0.57	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	34.90	3.96	4.72	1.69	0.42	1.35	1.77	0.42	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	34.33	3.29	3.29	1.65	0.59	1.06	1.53	0.12	0.47
seminal vesicle, adult	10201-103F3	3.70	20.63	16.40	7.41	2.12	5.29	0.53	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	3.89	14.09	17.49	6.07	0.24	1.21	0.49	0.24	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2.01	7.30	1.26	6.04	0.00	0.00	0.75	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	7.02	9.03	1.00	10.04	0.00	0.00	1.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	12.36	11.95	10.07	2.42	0.67	1.21	0.67	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	18.24	8.40	6.08	2.98	0.00	0.22	0.77	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	30.19	5.81	4.39	6.06	0.39	0.90	1.03	0.13	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	6.38	15.61	18.44	2.13	0.00	0.00	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	9.24	7.08	7.08	2.88	1.92	5.16	0.48	1.68	0.12
skeletal muscle, fetal, donor1	10066-101I3	9.05	17.09	28.14	10.05	1.01	0.00	1.01	0.00	3.02
skin, adult, donor1	10074-102A2	13.57	6.79	47.50	6.79	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	10.10	15.15	14.52	4.42	0.63	3.79	0.00	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	38.36	17.01	5.67	25.01	1.00	0.33	1.67	0.00	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	101.18	20.80	15.13	15.13	4.10	1.89	4.41	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	28.14	7.13	4.24	4.24	2.51	0.77	0.77	0.77	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	58.51	19.78	9.72	17.64	1.48	0.49	2.47	0.00	2.97
small cell lung carcinoma cell line:NCI-H82	10842-111E5	86.05	9.49	5.15	7.08	0.64	0.97	0.16	0.16	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	24.19	7.85	3.05	5.01	2.83	1.53	1.31	0.87	0.22
small intestine, adult, pool1	10024-101D6	7.52	6.93	6.45	2.99	2.15	3.22	0.12	0.96	0.00
small intestine, fetal, donor1	10064-101I1	11.79	10.56	14.00	5.90	1.23	3.44	0.49	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	28.21	6.67	15.90	1.54	0.00	0.00	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	4.39	21.45	27.91	3.62	2.58	5.17	0.00	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	31.63	6.70	9.11	5.90	0.00	0.27	0.54	0.80	0.80
spinal cord - adult, donor10196	10181-103D1	10.09	35.79	45.65	10.55	6.88	4.59	0.23	1.61	0.23
spinal cord, adult, donor10252	10159-103A6	20.11	23.26	26.81	5.91	8.67	5.91	0.00	3.55	0.00
spinal cord, adult, donor10258	10369-105F9	8.30	4.15	23.52	4.84	4.15	3.46	0.00	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	10.37	28.66	39.64	18.90	13.42	2.44	0.61	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	16.99	12.40	11.02	2.76	2.76	2.76	0.46	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.71	4.63	3.29	3.58	0.60	1.34	0.00	0.15	0.30
spleen, adult, pool1	10025-101D7	13.22	5.84	3.96	3.85	0.44	1.65	0.55	0.00	0.22
spleen, fetal, pool1	10044-101F8	23.76	8.66	7.15	5.32	1.19	2.86	0.72	0.72	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	54.55	5.90	3.83	3.73	0.10	0.62	3.93	0.52	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.84	8.35	2.47	13.67	0.19	0.57	0.95	0.00	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.18	11.18	2.45	5.94	3.49	0.70	0.70	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	56.29	8.60	4.30	7.04	0.78	0.00	1.95	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.26	7.09	9.79	2.03	0.45	0.23	2.81	0.11	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	53.80	7.62	4.66	7.62	0.85	0.42	2.54	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.46	7.19	2.12	6.77	0.00	0.42	1.27	0.00	0.00
stomach, fetal, donor1	10062-101H8	10.68	16.02	36.31	8.54	3.20	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	5.70	9.11	11.96	3.42	0.57	2.85	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	597.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	14.54	22.02	19.32	4.36	7.27	6.23	0.00	3.74	0.00
substantia nigra, adult, donor10258	10371-105G2	7.76	4.66	17.59	5.17	5.69	1.55	0.00	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	12.72	21.90	16.96	4.24	5.65	2.83	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	146.04	12.15	5.27	14.44	0.69	0.69	5.04	0.23	1.83
temporal lobe, adult, pool1	10031-101E4	20.26	28.82	45.27	4.92	22.04	9.92	0.51	3.98	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.02	60.54	97.58	24.93	7.83	2.85	0.71	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	44.83	37.36	64.61	10.99	1.76	0.44	0.88	0.88	0.00
tenocyte, donor1	11763-123H8	10.12	11.52	6.63	4.19	1.05	1.40	0.35	1.75	0.00
tenocyte, donor2	11765-123I1	5.34	8.01	5.34	3.43	1.91	4.58	0.00	1.53	0.00
tenocyte, donor3	11768-123I4	7.04	10.01	6.67	5.19	2.22	3.71	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	23.28	12.58	5.10	9.52	1.36	0.51	1.53	0.00	2.21
teratocarcinoma cell line:NCR-G1	10798-110I6	26.36	10.64	17.42	9.40	1.08	0.77	0.46	0.00	1.70
teratocarcinoma cell line:PA-1	10807-111A6	28.05	6.04	1.24	9.30	1.70	0.15	0.15	0.00	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	15.61	8.38	5.46	9.39	0.76	0.13	0.76	0.13	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	21.56	6.81	6.05	2.27	0.76	0.76	0.38	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	26.17	9.16	11.56	3.05	1.53	0.44	1.20	0.11	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	11.73	13.35	17.91	4.23	1.30	0.33	0.33	0.00	0.33
testis, adult, pool1	10026-101D8	9.56	17.18	16.64	6.98	8.91	9.77	0.43	2.47	0.75
testis, adult, pool2	10096-102C6	14.43	28.87	13.98	11.73	16.24	11.28	0.45	3.16	4.96
thalamus - adult, donor10196	10168-103B6	20.98	22.08	41.95	12.14	9.94	3.31	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	14.69	21.88	27.51	5.47	12.19	5.16	0.16	3.13	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	13.86	41.57	3.08	1.54	6.16	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.91	17.29	24.70	6.75	5.11	3.29	0.33	1.32	0.49
thalamus, newborn, donor10223	10366-105F6	43.72	12.08	27.04	9.78	4.03	2.30	4.60	0.00	1.73
throat, adult	10209-103G2	7.74	10.49	11.98	0.75	1.50	4.24	0.00	0.50	0.00
throat, fetal, donor1	10061-101H7	7.01	14.63	22.24	6.40	3.35	3.66	0.30	1.52	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	161.17	14.71	18.88	1.99	1.19	1.79	4.97	0.60	1.59
thymus, adult, pool1	10027-101D9	17.99	10.34	7.75	12.53	0.50	1.79	0.40	0.70	0.60
thymus, fetal, pool1	10043-101F7	20.16	12.78	12.05	12.26	1.77	2.60	0.52	0.62	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	18.08	8.51	2.53	6.52	0.00	0.40	1.46	0.00	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	30.17	10.62	6.71	7.96	1.12	0.98	0.84	0.14	0.98
thyroid, adult, pool1	10028-101E1	6.25	7.65	6.81	4.11	2.43	3.83	0.00	1.21	0.00
thyroid, fetal, donor1	10060-101H6	5.01	14.77	14.24	5.80	4.75	3.95	0.00	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	43.11	43.11	6.16	0.00	12.32	0.00	0.00	0.00
tongue, adult	10203-103F5	7.68	5.35	8.37	1.16	1.86	2.33	0.70	1.40	0.00
tongue, fetal, donor1	10059-101H5	10.25	12.22	8.67	3.55	2.36	2.76	0.39	0.00	0.39
tonsil, adult, pool1	10047-101G2	20.04	10.52	11.02	6.41	1.10	6.41	0.50	1.50	0.20
trachea, adult, pool1	10029-101E2	12.84	7.12	7.53	3.35	1.88	2.94	0.41	0.90	0.57
trachea, fetal, donor1	10058-101H4	9.62	16.54	20.39	3.46	2.31	3.46	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	9.21	13.82	4.96	5.67	0.35	0.71	0.71	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	45.19	9.93	1.72	13.27	0.10	0.10	2.74	0.00	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	67.53	15.04	4.54	12.38	0.31	0.94	1.57	0.16	1.88
tridermal teratoma cell line:HGRT	10694-109G1	9.51	24.73	15.22	15.22	11.42	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	9.82	4.66	5.08	2.79	0.93	0.76	0.08	0.25	0.25
umbilical cord, fetal, donor1	10057-101H3	4.17	8.35	16.69	2.09	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	17.06	15.87	17.06	2.90	2.05	6.65	0.34	1.19	0.34
uterus, fetal, donor1	10055-101H1	16.89	10.24	18.43	10.75	1.02	3.58	0.00	1.54	0.51
vagina, adult	10204-103F6	3.23	3.88	5.82	3.23	1.29	1.29	0.00	0.00	0.00
vein, adult	10191-103E2	9.21	8.33	14.69	2.63	1.97	2.85	0.00	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	27.77	5.61	0.80	4.81	0.53	2.14	1.34	0.53	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000586775.5:80 ENST00000585886.5:-101 BC018314:-101 BC072420:103 NM_001382242.1:108 NM_013433.5:108 NR_167974.1:108 NR_167979.1:108 ENST00000587654.5:-113 ENST00000589956.5:-116 AF019039:-131 LF373376:133 MA608953:133 NM_001136196.2:-136 NM_001382239.1:-136 NM_001382243.1:-136 NR_167978.1:-136 AK299485:-136 LF208193:-137 MA443770:-137 ENST00000592287.5:-148 BC063679:222 LF373377:229 MA608954:229 LF373378:356 MA608955:356" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.